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 Abstract 
Oligodeoxynucleotides (ODNs) containing latent electrophilic groups can be 
highly useful in antisense drug development and many other applications such as 
chemical biology and medicine, where covalent cross-linking of ODNs with mRNA, 
protein and ODN is required. However, such ODN analogues cannot be synthesized 
using traditional technologies due to the strongly nucleophilic conditions used in 
traditional deprotection/cleavage process. 
To solve this long lasting and highly challenging problem in nucleic acid 
chemistry, I used the 1,3-dithian-2-yl-methoxycarbonyl (Dmoc) function to protect the 
exo-amino groups on the nucleobases dA, dC and dG, and to design the linker between 
the nascent ODN and solid support. These protecting groups and linker are completely 
stable under all ODN synthesis conditions, but can be readily cleaved under non-
nucleophilic and nearly neutral conditions. As a result, the new ODN synthesis 
technology is universally useful for the synthesis of electrophilic ODNs. 
The dissertation is mainly comprised of two portions. In the first portion, the 
development of the Dmoc-based linker for ODN synthesis will be described. The 
construction of the dT-Dmoc-linker required a total of seven steps to synthesize. The 
linker was then anchored to the solid support―controlled pore glass (CPG). In the second 
portion, the syntheses of Dmoc-protected phosphoramidites ODN synthesis monomers 
including Dmoc-dC-amidite, Dmoc-dA-amidite, Dmoc-dG-amidite are described. The 
protection of dC and dA with 1,3-dithian-2-yl-methyl 4-nitrophenyl carbonate proceeded 
smoothly giving Dmoc-dC and Dmoc-dA in good yields. However, when the same 
xv 
 
 acylation procedure was applied for the synthesis of Dmoc-dG, very low yield was 
obtained. This problem was later solved using a highly innovative and environmentally 
benign procedure, which is expected to be widely useful for the acylation of the exo-
amino groups on nucleoside bases. The reactions to convert the Dmoc-protected 
nucleosides to phosphoramidite monomers proceeded smoothly with high yields. Using 
the Dmoc phosphoramidite monomers dA, dC, dG and the commercially available dT, 
and the Dmoc linker, four ODN sequences were synthesized. In all cases, excellent 
coupling yields were obtained. ODN deprotection/cleavage was achieved by using non-
nucleophilic oxidative conditions. The new technology is predicted to be universally 
useful for the synthesis of ODNs containing one or more electrophilic functionalities. 
xvi 
 
 Chapter 1  
Introduction 
1.1 General Introduction 
Conventional solid phase oligodeoxynucleotide (ODN) synthesis technologies 
utilize the succinyl ester linker to link ODN to solid supports and acyl groups to protect 
the exo-amino groups on the nucleoside bases. At the end of synthesis, the cleavage and 
deprotection of ODN requires strongly nucleophilic reagents such as ammonium 
hydroxide, sodium hydroxide and potassium methoxide. These methods work well for 
un-modified ODN sequences and modified ones that are stable under strongly basic and 
nucleophilic conditions. However, they cannot be used to synthesize ODN analogues that 
contain one or more electrophilic functionalities.  
ODN analogues that contain latent electrophilic groups are expected to find wide 
applications in research areas such as antisense drug development.1 Moreover, DNAs that 
are sensitive to bases and nucleophiles have been found in living cells and are believed to 
be important in biological processes. The synthesis of such model DNA will provide a 
basis for understanding the processes.2  
For the synthesis of nucleophile-labile ODNs, two types approaches have been 
used in literature. One type attempts to use traditional methods to make a stable ODN 
precursor, which is later functionalized with electrophilic moieties after cleavage and 
deprotection.3 These methods are inconvenient, have to be developed case by case and 
are not always feasible. The other approach uses protecting groups and linkers that can be 
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 cleaved under nearly neutral conditions. However, functionalities in organic chemistry 
suitable for the need are limited. The ones used in the literatures were the palladium-
removable allyl groups4 and the photo-labile o-nitrobenzyl linker5. ODN synthesis 
methods relying on them suffer from drawbacks such as high cost of palladium, difficulty 
to remove transition metal, and DNA photo damages. Besides the above two strategies, 
enzymatic reactions have also been used to access electrophilic ODNs.6 Drawbacks 
include high cost and narrow applications. 
1.2 Our Technology 
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Figure 1.1. CPG with dT-Dmoc linker and Dmoc-protected phosphoramidites 
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 To overcome the above problems in the synthesis of ODNs that contain sensitive 
functionalities, we designed the 1,3-dithian-2-yl-methoxycarbonyl (Dmoc) based 
protecting groups and linkers for ODN synthesis (1.1-1.4, Figure 1.1). The Dmoc-based 
groups and linkers are stable under all ODN synthesis conditions. During the post-
synthetic steps, oxidation of the sulfides in Dmoc groups drastically increase the acidity 
of H-2 in the 1,3-dithiane functions as shown in Scheme 1.1. The protecting groups and 
linkers can be cleaved under nearly neutral and non-nucleophilic conditions. 
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Scheme 1.1. Deprotection and cleavage of ODN protected and linked with Dmoc 
function 
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 The novelty of the design includes (i) an oxidatively-cleavable linker for ODN 
synthesis; (ii) protecting groups removable under non-nucleophilic oxidative condtions 
for ODN synthesis; and (iii) non-nucleophilic cleavage and deprotection conditions for 
ODN synthesis. 
The specific tasks for realizing the design has been described in the following 
chapters (Chapter 3-7). In Chapter 3, the feasibility of adapting Dmoc moieties for ODN 
synthesis is explored. In Chapter 4, the synthesis of dT-Dmoc-CPG 1.1 and its 
application in ODN synthesis is described. In Chapter 5, the syntheses of three Dmoc-
protected nucleoside phosphoramidite monomers (1.2-1.4) are reported and the non-
nucleophilic cleavage/deprtection conditions for ODN synthesis are disclosed in details. 
In Chapter 6, an improved synthesis of Dmoc-dG-amidite (1.4) is presented. In Chapter 
7, continuous efforts on enabling the synthesis of electrophilic ODNs are outlined. 
References 
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delivery systems: a comprehensive review. The AAPS journal 2005, 7 (1), 61-77. 
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Nucleic Acids Research 2003, 31 (2), 517-531. 
3. (a) Pande, P.; Shearer, J.; Yang, J. H.; Greenberg, W. A.; Rokita, S. E., Alkylation 
of nucleic acids by a model quinone methide. Journal of the American Chemical Society 
1999, 121 (29), 6773-6779; (b) Ali, M. M.; Oishi, M.; Nagatsugi, F.; Mori, K.; Nagasaki, 
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 Chapter 2  
History and Background 
2.1 The Overview of ODNs 
2.1.1 The origin of ODN research 
DNA research can be dated back to the mid of 19th century. At that time, ODNs 
were not considered as important substances. When Friedrich Miescher discovered DNA 
in 1869, he named it nuclein.1 DNA was considered as a high molecular weight polymer 
for over five decades. It didn’t attract significant attention from the scientific community. 
In early 1940s, Avery reported an altered transformation of bacteria in which DNAs were 
removed.2 Scientists realized that DNAs might be of genetic importance. Investigations 
on the structures and chemistry of DNA started since then.  
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Figure 2.1. Complementary base pairing 
Due to the advantage of X-ray crystallography technology, the structure of 
mononucleotides and double stranded nucleotides were elucidated. In 1953, Watson and 
Crick revealed one of the most important scientific discoveries. They built a double helix 
DNA model, which featured complementary base pairing (Figure 2.1). The model 
revealed how genetic information was coded in DNA.3 Later, Nirenberg and his 
6 
 
 coworkers reported their work on the translation of a poly-uracil polynucleotide into 
polypeptide in a cell-free system.4 The successful translation from nucleotide to protein 
uncovered the role of RNA and the process of gene expression. These discoveries 
ushered scientists entering into the era of molecular biology. 
At that time, Gobind Khorana believed that chemical synthesis of polynucleotides 
could be important for understanding the fundamental process in biology, which is from 
DNA to RNA to protein. During 1970s, Khorana and his group chemically synthesized a 
series of RNAs and DNAs.5 However few scientists shared Khorana’s vision. Many 
biologists thought his gene syntheses have little practical application. A striking turnover 
came in 1977. The groups of Itakura and Boyer demonstrated that the homone 
somatostatin could be expressed from a chemically synthesized gene in bacterium.6 This 
work set a milestone for the routine application of synthetic genes in the production of 
proteins. ODNs became invaluable assets in understanding the fundamental basis of 
genetic studies, and found wide applications in biological and biomedical research areas. 
2.1.2 The importance of ODNs 
2.1.2.1 ODNs in understanding fundamental biology 
The availability of synthetic ODN increased the momentum to nucleotide 
structure studies. While using the synthetic dinucleoside phosphate ApU, Rich’s group 
and Klug’s group discovered a series of alternative base pairs and base triples other than 
traditional Watson-Crick complimentary paring (Figure 2.1).7 Later, Wang discovered a 
left-handed Z-conformation in synthetic d(CGCGCG).8 Followed a sequence of 
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 demonstration of synthetic ODNs in a B-DNA helix by Dickerson9 and a A-DNA helix 
by Kennard,10 the idea that DNA has a stubborn, rod-like structure was concluded. 
Synthetic ODNs also provide opportunities to study the interactions between 
DNAs and other molecules, such as mutagens, carcinogens and proteins. One example is 
the research on the mutagenic 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 
a heterocyclic amines found abundant in cooked meat. Because this heterocyclic amine is 
believed to be mutagen and carcinogen after their metabolic activation and subsequent 
binding with DNAs,11 a synthetic dG-C8-PhIP ODN was synthesized by Fukuda to 
uncover the molecular mechanism of the PhIP induced mutation.12 Another example is 
the investigations on the interactions of DNAs with proteins. In a report published by 
Bazzi and his coworker, a synthetic mini-cTAR ODN was applied to bind with a HIV-1 
nucleocapsid protein. With the structure insights obtained from nuclear magnetic 
resonance and gel retardation assays, they concluded that the binding activity between 
ODN and protein is based on the conformation differences, such as major and minor 
grooves.13, 14 
2.1.2.2 ODNs in biotechnology 
In the last 30 years, biotechnology has reshaped the life science. Synthetic ODNs 
are one of the fundamentals for such advances. For example, ODNs are required in DNA 
sequencing, cloning and gene detection.15  
In classical Sanger DNA sequencing, a short ODN primer was hybridized with a 
single stranded DNA template.16 Through enzymatic reaction, the elongation from the 
primer was achieved by incorporating normal deoxynucleosidetriphosphates (dNTPs). 
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 During the elongation process, dideoxynucleosidetriphosphates (ddNTPs) were 
introduced to terminate the elongation. Gel electrophoresis analysis of the DNA 
sequences with different length reveals the sequence of template DNA. Since the DNA 
polymerase can only start from a primer hybridized to the template, chemically 
synthesized ODN is required for the production of the desired double stranded DNA. 
PCR is a technology that amplifies a piece of DNA by generating millions of 
copies of template DNA.17 Similar to DNA sequencing, the concept of PCR is elongating 
DNA sequences on ODN primers through enzymatic reaction. The difference is that the 
template is a double stranded DNA instead of single strand one. Thus, two ODN primers 
are used. One primer is complementary to the 3ʹ end of one DNA strand, while the other 
primer is hybridized to the 3ʹ end of the other DNA strand. The elongation will be 
terminated when reaching the restriction sites at 5ʹ ends of each DNA strand. Nowadays, 
many DNA sequences are known for organisms. Thus, utilizing various chemically 
synthesized ODN primers, PCR can easily provide DNAs or genes with interests. 
DNA fingerprinting is another important technology that require synthetic 
ODNs.18 In DNA fingerprinting, photo or radio labeled ODNs, called ODN probes are 
used to hybridize with hypervariables in sample solution. The resulting double-stranded 
DNA fragments are separated by gel electrophoresis and detected by the fluorescence or 
radio activity. Based on the hybridization assay, specific gene sequence in sample can be 
readily deleted. This technology is widely used in forensic studies. 
ODN microarrays, also called DNA chips, are miniature parallel analytical 
devices containing libraries of oligonucleotides robotically spotted or synthesized on 
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 solid surfaces (glass, coated glass, silicon or plastic).19 Treated with a solution of 
fluorescently labeled ODNs (also called mobile probes), the target oligonucleotides can 
be identified by detecting fluorescence of the hybridized ODNs. This technology 
provides a classified gene inventory for living organisms.  
Recently, researchers have also found other important application of ODNs and 
ODN analogues, such as in antisense therapeutic study, modulating gene expression and 
constructing DNA chips.20 These important research projects are not possible without 
advances on ODN synthesis methodology. 
2.2 ODN Synthesis 
2.2.1 The history of ODN synthesis 
2.2.1.1 First dinucleotide  
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Figure 2.2. Synthesis of first dinucleotide 
The first chemical synthesis of an ODN was reported by Michelson and Todd in 
1955.21 In their report, two thymidine nucleosides were linked together by the formation 
of a phosphate internucleotide linkage (Figure 2.2). They first prepared two starting 
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 materials. One of them is the thymidine phosphoryl chloride 2.1. The other is 3ʹ-benzoyl 
deoxythymidine (dT) 2.2. The two were then reacted with each other to give the 
dinucleotide product 2.3.  
2.2.1.2 Phosphodiester method 
Inspired by Todd’s work, Khorana’s group continued the studies on ODN 
synthesis. In the protocol he and his coworkers published in 1956, the phosphodiester 
method was developed for ODN synthesis (Figure 2.3).22 Instead of using the easily 
hydrolyzable phosphoryl chloride as starting materials, they prepared nucleoside 
phosphates. These nucleoside phosphates were subsequently activated using a 
condensation reagent. For example, the DMTr-protected thymidine phosphate 2.4 was 
activated with dicyclohexyl carbodiimide (DCC) and reacted with 2.5 to give the 
dithymidine nucleotide 2.6. 
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Figure 2.3. Phosphodiester approach 
Since the phosphate itself was not protected, branching at the internucleotide 
phosphate linkages from the previous couplings became a problem. As the 
11 
 
 oligonucleotide length increased, the percentage of branching also increases and makes 
the purification of ODN a challenging task. 
2.2.1.3 The introduction of solid phase chemistry to ODN synthesis 
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Figure 2.4. Coupling of dC to polymer solid support 
In the early 1960s, solid phase chemistry has been successfully applied to organic 
synthesis and peptide synthesis. Robert Letsinger was the first to adapt the technology to 
ODN synthesis. In his paper published in 1965, he described the synthesis of dimer and 
trimer ODNs using the styrene-divinylbenzene polymer as solid support.23 As shown in 
Figure 2.4, the polymer support was first modified with acetic chloride and gave the 
modified polymer support 2.7. With both 3ʹ- and 5ʹ- hydroxyl groups protected by 
dimethoxytrityl (DMTr) and benzoyl groups, the 4-amino groups of protected 
deoxycytidine (dC) 2.8 reacted with the solid support 2.7. The DMTr group was then 
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 removed with mild acid to prepare for the coupling of next nucleoside. The attachment to 
solid support 2.9 was cleaved with strong bases and released the ODN.  
2.2.1.4 Phosphotriester method 
In 1969, Letstinger’s group published a series of papers describing the 
phosphotriester method for ODN synthesis. For example, as shown in Figure 2.5, 2-
cyanoethyl protected dT phosphate 2.10 reacted with dC-linked polymer support 2.11 and 
gave phosphotriester 2.12.24 The major advance of this method was the protection of the 
phosphate group that prevents the branching on internucleotide linkage. The protecting 
group used was the β-cyanoethyl group which could be easily removed with ammonium 
hydroxide through β-elimination. 
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Figure 2.5. Phosphotriester Approach 
The major drawback for phosphotriester chemistry is the low average step-wise 
yield, which often fell below 95%. The inefficient coupling limited the routine synthesis 
of ODN to the length of less than 20 bases.  
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 2.2.1.5 Phosphite-triester method 
In the mid-1970s, Letsinger’s continuous efforts in ODN synthesis led to the 
development of a new ODN synthesis method-the phosphite-triester method (Figure 
2.6).25 This chemistry is based on the highly reactive nucleoside phosphorus(III) 
chlorides such as 2.13. Phosphorus(III) chlorides are much more reactive than the 
previous used phosphorus(V) chlorides. The synthesis process required an additional 
step-oxidation to prepare the natural P(V) backbone. This chemistry significantly reduced 
the coupling time due to the highly reactive nature of the nucleoside phosphorochloridite. 
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Figure 2.6. Phosphite-triester approach 
The research community quickly accepted the new chemistry. However, the 
phosphite-triester method still has one serious drawback. The nucleoside 
phosphorochloridite intermediate is highly sensitive to moisture and air. Each nucleoside 
phosphorochloridite must be freshly synthesized prior to coupling.  
2.2.2 The most widely used phosphoramidite chemistry 
Due to the drawbacks of phosphite-triester method, research on inventing new 
coupling reactions for ODN synthesis continues. In 1980s, Marvin Caruthers’ research 
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 group developed the phosphoramidite approach. He and his coworkers solved two major 
problems. One is the swelling problem of solid supports, which was overcome by using 
controlled pore glass (CPG). The other problem they solved was the instability of 
nucleoside intermediates. They utilized the nucleoside phosphoramidites as the 
intermediates, which are much more stable than phosphites.   The phosphoramidite 
chemistry became the most widely used technology of ODN synthesis, and the core 
barely changed over the years.26 The general synthesis cycle of phosphoramidite 
chemistry (Figure 2.7) includes 4 steps, which are described in the following sections.  
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Figure 2.7. ODN synthesis cycle using phosphoramidite chemistry 
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 2.2.2.1 Detritylation 
The 5ʹ-OH group of nucleoside phosphoramidite are protected with a 4.4ʹ-
dimethoxytrityl (DMTr) group. As a result, the 5ʹ-end of growing ODN on solid support 
has a DMTr group. The first step in a synthesis cycle is to remove this protecting group, 
which is called detritylation. Detritylation is achieved by the treatment with 
trichloroacetic acid. The mechanism of the removal of DMTr group is shown in Figure 
2.8. 
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Figure 2.8. Detritylation 
2.2.2.2 Coupling 
Following detritylation, a large excess of nucleoside phosphoramidite solution in 
acetonitrile was added to the solid support. Activated by tetrazole or other weakly acidic 
activators, the diisopropylamino group of nucleoside phosphoramidite 2.19 is protonated 
and converts to a good leaving group. The coupling of two nucleosides is achieved by the 
nucleophilic attack from support-bound nucleoside 2.20 to nucleoside phosphoramidite 
2.19 (Figure 2.9). 
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Figure 2.9. Coupling 
2.2.2.3 Capping 
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Figure 2.10. Capping failure sequence 
Since a yield of 100% is not achievable even for the most efficient reaction, there 
will always be a few support-bound nucleosides which haven’t reacted with the 
nucleoside phosphoramidite during the coupling step. The unreacted 5ʹ-OH groups of the 
failed coupling will react with next nucleoside base in the following coupling. The 
resulted ODN sequence will be missing one base. Without appropriate check, these ODN 
failure sequences with missing bases would accumulate from each successive cycle, and 
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 the final product would be a complex mixture of ODNs. These ODN failure sequences 
will carry incorrect genetic information, and be difficult to remove. 
By introducing a capping step right after coupling, the unreacted 5′-hydroxyl 
groups will be blocked with acetyl groups and be voided reacting with the nucleoside 
phosphoramidite in the next synthesis cycles.  
Capping reagents acetic anhydride and N-methylimidazole (NMI) are dissolved in 
tetrahydrofuran with the addition of a small quantity of pyridine. The mixture is then 
delivered to the solid support. As shown in Figure 2.10, the electrophilic mixture rapidly 
acetylates alcohols and caps the reactive 5ʹ-hydroxy groups on the failure sequence 2.21. 
The presence of pyridine ensures that the pH remains basic so that the nucleoside 
phosphoramidite won’t be detritylated. 
2.2.2.4 Oxidation 
The phosphite-triester formed in the coupling step is unstable to acid and must be 
converted to a stable P(V) species prior to the next detritylation step. This is achieved by 
iodine oxidation in the presence of water and pyridine (Figure 2.11).  
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Figure 2.11. Oxidation of P(III) to P(V) 
2.2.2.5 Automation 
The combination of the highly efficient phophoramidite chemistry for the 
formation of internucleotide phosphate linkage with solid phase methodology led to the 
automation of ODN synthesis. Caruthers designed a DNA synthesizer based on 
phosphoramidite chemistry and set up a company called ABI. The typical process used in 
phosphoramidite chemistry synthesizer is shown below in Table 2.1. 
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 Table 2.1.  Step durations in a typical cycle using phosphoramidite chemistry 
Operation Reagent/solvent Time 
Detritylate 3% trichloroacetic acid in dichloromethane 50 s 
Couple 0.1 M phosphoramidite monomer and 0.5 M tetrazole in acetonitrile 30 s 
Cap 
acetic anhydride/pyridine/THF 1/1/8 and 17.6% w/v N-methyl 
imidazole in acetonitrile 30 s 
Oxidize 0.015 M iodine in water/pyridine/THF 2/20/78 45 s 
2.2.3 Cleavage and deprotection 
2.2.3.1 Cleavage from solid support 
Mostly, the ODNs are synthesized on solid support through the succinyl linker. 
This linker is readily cleaved by treatment with concentrated ammonium hydroxide at 
room temperature for one hour (Figure 2.12). The cleavage reaction is carried out 
automatically on some synthesizers. The ammonium solution containing the ODNs is 
delivered to a glass vial. Alternatively, the cleavage can be carried out manually by 
taking the column off the synthesizer and washing the solid support with ammonium 
hydroxide solution. 
2.2.3.2 Deprotection of phosphodiester backbone 
 The phosphate groups are protected with β-cyanoethyl groups throughout ODN 
synthesis, and must be deprotected to obtain the desired ODNs. As shown in Figure 2.12, 
the cyanoethyl groups can also be removed by ammonium hydroxide through β-
elimination. 
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 2.2.3.3 Deprotection of nucleic bases  
The exocyclic amino groups on the heterocyclic bases (A, C, and G) are protected 
during oligonucleotide synthesis. As mentioned earlier, different protecting groups are 
applied on different nucleoside bases. The benzoyl groups on A and C are cleaved readily 
in ammonium hydroxide, but the isobutyryl protecting group on guanine is much more 
resistant to ester hydrolysis. With treatment of concentrated ammonium hydroxide at 55 
ºC for 5 hours, isobutyryl groups can be removed quantitatively (Figure 2.12).  
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Figure 2.12. Cleavage and deprotection of ODN 
2.2.3.4 Scavenging of by-products 
Acrylonitrile, a by-product of phosphotriester deprotection, is a Michael acceptor. 
Under the strong basic conditions used for ODN deprotection, 2-cyanoethyl adducts can 
react with the hetereocyclic bases through Michael addition (Figure 2.13). Thereby, the 
product will be Michael conjugates of ODNs and the desired ODN won’t be obtained. By 
treating with a solution of a weak base in an organic solvent (e.g. 10% diethylamine in 
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 acetontrile, or 1:1 triethylamine/acetonitrile), the acrylonitrile can be scavenged and its 
reaction with nucleoside bases can be avoided. 
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Figure 2.13. Michael addition to nucleoside base 
2.2.4 Purification of ODNs 
The most commonly used purification methods are polyacrylamide gel 
electrophoresis (PAGE) and high performance liquid chromatography (HPLC). The 
choice of ODN purification method depends on the ODN applications.  
Electrophoresis using high percentage acrylamide gels is the most efficient 
method to separate the full-length product from all shorter species. Although it is 
impossible to recover all full-length ODN products from a gel, the loss from PAGE is 
typically acceptable considering the high purity. PAGE is strongly recommended for the 
purification of ODNs with over 60 bases in length. 
HPLC is a chromatographic technique that utilizes a column to hold a stationary 
phase while the sample is eluted within a mobile phase. Due to specific chemical and 
physical properties, each analyte interacts with the stationary phase or mobile phase 
differently. Therefore, each analyte has an unique retention time. HPLC is usually 
reserved for ODNs that have been modified, such as ODNs with the addition of a linker 
or spacer, a non-standard base or bases, or hydrophobic molecules. Based on the 
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 differences on solvent affinity or net charge, ODNs can be separated by reverse-phase 
HPLC or ion-exchange HPLC with high resolution. 
2.2.5 Characterization of ODNs 
The widely used ODN characterization methods are electrospray ionization (ESI) 
mass spectrometry and matrix-assisted laser desorption/ionization-time of flight 
(MALDI-TOF) mass spectrometry. 
ESI mass spectrometry can give mass of long ODNs (up to ~150 bases in length). 
The ODNs are dissolved with a solvent and are injected into electrospray chamber. Once 
the solvent is evaporated, the ions will separate from each other and reach the detector at 
different times. The detector will measure the mass to charge ratio of each ion, from 
which the molecular weight of ODN can be deduced. 
MALDI-TOF mass spectrometry is a useful tool for the mass determination of 
ODNs up to 50 bases in length (~15,000 Daltons).  The concept of MALDI-TOF is based 
on that the speed of an ion is proportional to its mass. ODN samples are ionized and 
moved by a certain potential energy. By detecting the arrival time of each ion, the 
molecular weight of ODNs can be calculated.  
2.3 The Modifications of ODN 
Due to the advances on ODN chemical synthesis, various modifications can be 
made on ODNs. The derived ODN analogues have been found or are predicted to have 
wide applications as therapeutic agents and biosensors. 
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 2.3.1 Backbone modification 
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Figure 2.14. Synthesis of phosphothioates 
The phosphate backbones of natural ODNs are degraded by nucleases easily and 
have limited the ODN application toward in vivo antisense therapeutic study. Eckstein’s 
group replaced the P-O bond of phosphate with a P-S bond on the internucleotide 
linkage.27 The resulted phosphothioates greatly enhance the nuclease stability of ODNs.28 
When phosphothioates hybridize with RNA, the lifetime of the helix is prolonged. Thus, 
phosphothioates are expected to be potential antisense therapeutics.29  
 
Figure 2.15. Modifications on sugar moiety 
With the chiral center on phosphorus, phosphothiate can also be applied in 
studying the stereo activity of enzymatic reactions. Due to the ability of binding with 
“soft” metals, phosphothiate is very useful in investigating the interference activity with 
small molecules.30 The synthesis of phosphothioates can be easily achieved by utilizing 
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 sulfurizing reagents (such as 3H-1,2-benzodithole-3-one-1,1-dioxide) in the oxidation 
step (Figure 2.14).31  
Modifications of sugar moiety are usually conducted on 2ʹ position. The 
modifications on 2ʹ position with methoxy, fluoro, amino and allyloxy groups were 
employed to probe hammerhead ribozyme catalysis.32 
 
Figure 2.16. Synthesis of PNA 
Peptide nucleic acids (PNAs) are a type of modified nucleic acid analogues 
without traditional phosphate backbone. PNA was first introduced by Buchardt and 
Nielsen in 1980s.33 The general synthesis of PNA is shown in Figure 2.16.With a 2-
aminoethyl-glycine linkage, the simple synthetic molecule is non-ionic, achiral, and 
stable towards nuclease. At the same time, the nucleoside bases are anchored to PNA 
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 backbone via a carbonyl linker. Thus PNAs are able to complementarily pairing with 
bases on DNAs or RNAs. PNAs are considered as potential drug candidates for antisense 
therapy. In Norden’s review paper, the roles of PNAs as antigene drugs and molecular 
tools were discussed in details.34 
2.3.2 Terminus modification 
An important group of modified ODNs are ODN analogues with labeling groups 
at the terminus. For examples, ODNs are functionalized with fluorophores, radioactive 
moieties, and biotins on the 5ʹ- and 3ʹ-terminals.35 These ODNs analogues are very useful 
in areas, such as quantifying, identifying and isolating oligonucleotides. For example, 
based on the strong interaction of biotin with streptavidin, ODN biotinylated with the 
reagent shown in Figure 2.17 can be easily separated from other molecules. 
 
Figure 2.17. Biotinylation on 3ʹ and 5ʹ terminus 
ODNs with linkers have also become important substrates in biology study. Like 
the linkers shown in Figure 2.18, which can generate terminal reactive groups (amino or 
thio groups), they can conjugate ODNs to other biomolecules and increase the 
interference ability.36  
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Figure 2.18. ODNs with linkers 
The synthesis of these terminus modifications can be achieved using specific 
modified phosphoramidites. Reaction of ODNs with appropriate reagents after ODN 
synthesis cycle can also give ODNs on 5ʹ or 3ʹ terminus. Another convenient synthesis 
method for terminus modified ODNs is enzymatic ligation.37 
2.3.3 Base modification 
More ODN modifications were done on the nucleoside bases. The heterocyclic 
rings of purine and pyrimidine bases provide hydrogen-bonding moieties that are the 
most important contributors to DNA stability and reactivity. Modifications on the 
heterocyclic rings would drastically change the DNA stability and affect the interaction 
between DNA and other molecules. 
Numbers of base-modified nucleoside phosphoramadites are commercially 
available for the synthesis of ODN analogues. Using different synthesis methods 
with/without protecting groups, base modifications can be achieved through 
phosphoramidite chemistry.  
Carefully designed base analogues are extremely useful in improving the 
interaction in DNA, RNA, or nucleic acid-protein complexes.38 For example, 5-propynyl-
dU (Figure 2.19) allows improved stacking ability with neighbouring bases in DNA 
duplexes. 8-Hydroxy-dG (Figure 2.19), a DNA lesion caused by reactive oxygen species 
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 (ROS) is believed to play an important role in mutagenesis. The synthesis of 8-hydroxy-
dG will provide basic research substrate for understanding the process that how damaged 
DNAs disturb the genetic information heredity.39 2-Amino-6-vinylpurine 
deoxynucleotide (Figure 2.19) is designed by Sasaki as a cross-linking reagent. It could 
form a covalent bond with cytosine on RNA. The cross-linking activity is expected to be 
employed for the inhibition of gene expression.40 The modified ODNs analogues can 
form a nucleotide pool for antisense or antigene therapeutic studies. 
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Figure 2.19. Modifications on nucleoside bases 
2.4 Perspectives 
With the development in ODN synthesis, chemically synthesized ODNs have 
been successfully employed in biology and biotechnology. Particularly, the tailor-made 
ODN analogues have been and are expected to play important roles in understanding 
biochemical processes and act as invaluable tools in biomedical area. However, a great 
challenge remains. To date, only the modifications that are relatively stable have been 
evaluated. Due to the harsh conditions of current ODN synthesis technology, many ODN 
analogues, such as ODNs with electrophilic functionalities, are not accessible. Novel 
synthesis strategies, such as new protecting strategy that can perform deprotection under 
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 very mild conditions, are in urgent needs to fully unlock the potential of ODNs and ODN 
analogues. 
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Chapter 3  
Feasibility Studies 
Abstract 
The feasibility of using the Dmoc function for  ODN synthesis was evaluated in 
two respects: (1) the stability of Dmoc function under conditions of ODN synthesis 
using phosphoramidite chemistry; (2) the appropriate oxidation conditions for removing 
Dmoc moieties. With these investigations, we demonstrated the feasibility of designed 
Dmoc-based cleavage and protection strategy for ODN synthesis. 
3.1 Introduction 
Dmoc moiety was first introduced by Kunz’s group and have been successfully 
applied applied to glycopeptide synthesis.1 In Kunz and his coworkers’ work, Dmoc 
groups are inert to acids and bases, but after oxidation of the sulfur to sulfone, they can 
be cleaved by β-elimination. Thus, Dmoc groups are expected to be good protecting 
groups for organic synthesis. Surprisingly, we found little research of Dmoc for other 
applications. 
In our strategy for ODN cleavage and deprotection, we will synthesize dT-
Dmoc-CPG (1.1), Dmoc-dC-amidite (1.2), Dmoc-dA-amidite (1.3) and Dmoc-dG-
amidite (1.4), and apply these compounds in ODN synthesis using phosphoramidite 
chemistry. With appropriate oxidizing conditions, the sulfide of Dmoc moieties will be 
converted to sulfoxide or sulfone, which intrigues β-elimination for simultaneous 
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deprotection and cleavage. Prior to synthesizing these compounds, the feasibility of the 
Dmoc-based ODN synthetic strategy need to be demonstrated in two respects: (1) the 
stability of Dmoc moieties through phosphoramidite chemistry; (2) the appropriate 
oxidation conditions for removing Dmoc moieties. 
Since the sulfides in the Dmoc group are accessible to oxidation, the potential 
reaction of sulfide with iodine that is used for the convertion of P(III) to P(IV) in ODN 
synthesis is a great concern. To use the Dmoc moiety for ODN synthesis by 
phosphoramidite chemistry, experiments have to been carried out to demonstrate that 
sulfide wouldn’t react with iodine under the ODN synthesis conditions. 
It is known that ODNs can potentially be damaged under oxidative conditions. 
As Dmoc groups are desgined to be removed under oxidative conditions, an oxidative 
condition that can oxidize Dmoc but won’t cause ODN damages is needed for using 
Dmoc for ODN synthesis. From literature search, we found certain oxidizing reagents, 
such as (1S)-(+)-(10-camphorsulfonyl)oxaziridine (CSO), H2O2 and NaIO4, have been 
applied in ODN research without damaging ODNs.2 However these oxidants have never 
been used for removing Dmoc moieties. Screening for oxidants that can rapidly oxidize 
the sulfides in Dmoc function while do not oxidize DNA is needed. 
In this chapter, we will explore the stability of Dmoc moieties in the presence of 
iodine and screen several oxidizing reagents for oxidizing the Dmoc moiety. With these 
investigations, we will be able to predict the feasibility of using the Dmoc function for 
ODN synthesis. 
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3.2 Results and Discussion 
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Scheme 3.1. Evaluation of the reactivity of sulfides with I2 
To evaluate the reactivity of sulfides with iodine, phenyl methyl sulfide (3.1) 
and dibenzyl sulfide (3.3) were chosen as substrates. The evaluation was carried out 
with 0.02M iodine in THF/pyridine/H2O, which is the oxidizing conditions used in 
ODN synthesis using the phoshporamidite chemistry (Scheme 3.1). Excess iodine (10 
equivalent) was used.   The resulting reaction mixture were analyzed by gas 
chromatography-mass spectrometry after periods of 1 hour, 3 hours and 6 hours, 
respectively. From the results of GC/MS analysis, starting materials 3.1 and 3.3 were 
the major peaks and no oxidized products (3.2 and 3.4) were found.  
 
Scheme 3.2. Screening of conditions for the oxidation of 1,3-dithiane 
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Figure 3.1. Incubation of authentic ODN with NaIO4 
In ODN synthesis, the reaction time for oxidation in each cycle is only 45 
seconds. The total oxidation time for a 20-mer ODN synthesis is about 15 minutes. As 
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no oxidation occurred on these two sulfides during six hours period, the sulfides of 
Dmoc moiety should be inert to oxidizing conditions used for ODN synthesis. Thus we 
shall not expect premature oxidative cleavage of Dmoc by I2 during ODN synthesis. 
As mentioned earlier, CSO, H2O2, NaIO4 and m-CPBA have been used as 
oxidants in ODN studies without damaging ODN. A proof is shown in Figure 3.2. 
Authentic ODN sample was incubated with NaIO4 solution for 12 hours. The resulted 
mixture was analyzed by HPLC. The profile is shown in trace c. The same retention 
times shown in trace a and c suggested that ODN was not damged. The mass obtained 
from MALDI-TOF further proved that ODN was stable through the incubation of 
NaIO4.  
Next, the screening of reagents to oxidize Dmoc was carried out by reacting 1,3-
dithiane with each oxidizing reagent. Oxidizing conditions were shown in Scheme 3.2. 
The resulting reaction mixtures were partitioned between CH2Cl2 and water. The 
organic layers were then analyzed by GC/MS. From the analysis of GC/MS results, we 
found that: (1) CSO gave very little oxidized products; (2) 10% H2O2 aqueous solution 
converted 1,3-dithiane (3.5) completely to oxidized derivatives (3.6-3.8) in 1 hour and 
3.8 was the major product; (3) 30% H2O2 aqueous only gave 3.8 as product after 2 
hours reaction.  
3.3 Conclusion 
The reaction of sulfide with iodines didn’t give oxidized derivatives. 1,3-
Dithiane were converted to sulfoxides or sulfone under the oxidizing conditions which 
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were intert to ODNs. With these investigations, we proved the feasibility of using Dmoc 
function for ODN synthesis.  
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Chapter 4  
Synthesis of Dmoc-dT Linker and Evaluation of Its Application in ODN 
Synthesis1  
Abstract 
A novel linker for oligodeoxynucleotide (ODN) synthesis utilizing 1,3-dithiane-2-
yl-methoxycarbonyl (Dmoc) moiety was synthesized. The resulting dT-Dmoc CPG was 
successfully applied for the automated ODN synthesis.  Efficient cleavage from solid 
support was achieved under non-nucleophilic oxidative conditions. 
4.1 Introduction 
ODN chemical synthesis has been extensively studied in the past six decades. 
Since Letsinger introduced solid phase chemistry to ODN synthesis,1 solid phase ODN 
synthesis became the most widely used method for ODN synthesis in both research labs 
and manufacturer millers. Compared to other ODN synthesis methods (such as solution 
phase, enzyme ligation), the advantages of solid phase ODN synthesis are vivid. There 
are three main reasons contributing to the widely acceptance of the solid phase 
technique.2 (i)  Simple chemical process. Usually the completion of reactions only require 
three simple steps: reagents addition, filtration and resin washing. Due to the convenience 
1 The contents of Chapter 4 were adapted into a journal paper “Oligonucleotide Synthesis 
Using Protecting Groups and a Linker Cleavable under Non-nucleophilic Conditions”. 
This paper has been submitted to the Chemical Communication for peer review. 
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of conducting reactions, reactions with repeated cycles can be automated with equipped 
instruments. (ii) Easy purification. In a multiple-step solid phase synthesis, the only 
purification needed is washing resin with massive solvents until the final product is 
attained on the solid support. (iii) High reaction efficiency. Because excess reagents can 
be used, the reaction efficiency could be driven to quantitative level.   
To successfully accomplish a solid phase ODN synthesis, two problems need to 
be addressed. They are: (i) what solid support to choose; and (ii) what linkage method to 
use for attaching materials to solid support and what cleavage method to use for cleaving 
materials from solid support.  
Unlike the swellable solid support used in organic solid-phase synthesis and 
peptide synthesis, the best solid supports that work for ODN synthesis are non-swellable 
or low swellable materials. Controlled pore glass (CPG) and macroporous polystyrene 
(MPPS) are the most commonly used solid supports in ODN synthesis.3 In order to 
recover the ODN from solid support after completion of synthesis, a cleavable linker has 
to be introduced to between the ODN and solid support.  
 
Figure 4.1. Solid supports for OGN synthesis 
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Conventionally, two types of linkers are used (Figure 4.1). (i) Non-nucleosidic 
linkers (universal linkers).3a Prior to assembling nucleoside blocks, a non-nucleosidic 
linker is attached to the amino group of the solid support and forms a non-nucleosidic 
solid support. For example, in the ODN synthesis using solid support 4.1, DMTr group of 
4.1 was removed in the first synthetic cycle. The uncovered hydroxyl group was 
covalently bonded to the phosphorus atom of nucleoside phosphoramidite. Once the 
chain reaction was completed, the expected ODN could be obtained using treatment with 
strong bases by cleaving the P-O bond at 3ʹ-terminus of nucleotide. This type of linker 
can be universally used to synthesize any oligonucleotide sequence, thus, non-nucleosidic 
linker is known as universal linker. (ii) Nucleosidic Linkers.4 With this approach, a 
nucleoside is first attached to the solid support via, most often, succinyl arm. The 
produced nucleosidic solid support is then used for the oligonucleotide chain assembly. 
For example, when applying solid support 4.2 in ODN synthesis, detritylated 4.2 would 
react with nucleoside phosphoramitidite. At the end of the synthesis, the nucleoside of 4.2 
became the 3ʹ-terminus of the synthesized ODN. The ODN product is obtained through 
ester hydrolysis under strongly basic and nucleophilic conditions. Both non-nucleosidic 
and nucleosidic solid supports require strong nucleophilic reagents for ODN cleavage, 
such as gaseous ammonia, aqueous ammonium hydroxide, NaOH, KOH, or potassium 
methoxide (K2CO3 in anhydrous methanol).3-5 
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  Figure 4.2. Linkers for electrophilic ODN synthesis 
However, many modified ODN syntheses, particularly the syntheses of ODNs 
that contain one or more latent electrophilic groups, are not compatible with the strongly 
nucleophilic conditions. With increasing interests of using these ODN analogues as 
diagnostic probes and therapeutics, new linking approaches to solid support are needed.6  
A variety of linkers have been developed for ODN synthesis to solve the problem. 
Lyttle reported a universal CPG solid support by immobilizing 1-O-(4,4̓ dimehtoxytriyl)-
2-O-succinoyl-3-N-allyloxycarbonylpropane (4.3, in Figure 4.2).7 Under very mild 
alkaline conditions (aqueous TEAA/NH3 buffer, pH=10, room temperature), the 3-N-
allyloxycarbonyl group was removed from the linker. Further, the derived amino group 
attacked the 3̓-terminal phosphate group and released the desired ODN from CPG. 
However in this protocol, the key to a successful cleavage relied on the removal of the 
allyoxycarbonyl group, which can only be allowed with the mediation of Palladium(0). 
Due to the difficulty to remove palladium from product, this type of linker is not favored 
for ODN synthesis, and is not applicable for the synthesis of ODNs with therapeutic 
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applications.  Another linker 4.4 utilizing a silyl moiety was reported by Ohkubo’s 
groups to synthesize modified ODN under almost neutral condition.8 In their report, the 
silyl-type linker could be cleaved by treating with 0.2 M Et3N/3HF at room temperature. 
Albeit of the mild alkaline condition, HF is a highly toxic reagent and is not very 
compatible with CPG. Photocleavable linkers are another genre of linkers which are 
widely explored.9 For example, the linker 4.5 was used for ODN synthesis. Based on the 
photochemistry of O-nitrobenzyl group, the desired ODN can be cleaved from the solid 
support using either a transilluminator (λmax 365 nm) or the 400 nm band from a high-
pressure Hg/Xe lamp. However the unpredictible photo damages on ODNs has 
discouraged the application of photo labile linkers. 
O
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Figure 4.3. dT-Dmoc Linker 
To solve the problem, we designed a novel oxidatively-cleavable dT-Dmoc linker 
4.6 for ODN synthesis. This dT-Dmoc linker is stable under all ODN synthesis 
conditions. Upon oxidation of the dithianyl moiety, the linker can be cleaved under non-
nucleophilic conditions. This new linker is universally useful for the synthesis of un-
46 
  
modified ODNs and modified ODN analogues including those that contain base-labile 
and electrophilic groups. 
4.2 Results and Discussion 
 
Scheme 4.1. Synthesis of dT-Dmoc linker 4.6 
To carry out an ODN synthesis under non-nucleophilic cleavage condition 
utilizing the Dmoc functionality, the oxidatively cleavable dT-Dmoc linker 4.6 needs to 
be synthesized. The preparation of dT-Dmoc linker 4.6 is shown in Scheme 4.1. The 
DMTr protected deoxythymidine 4.9 was obtained from the tritylation of deoxythymidine. 
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tert-Butyldimehtyl siloxyl pentanal 4.8 was produced from swern oxidation of 4.7, which 
was derived from pentandiol. The anion generated by treating 1,3-dithiane with t-BuLi 
was then reacted with 5-((tert-butyldimethylsilyl) oxy)pentanal (4.8) to give 4.10, which 
was converted to 4.11 by reacting with 1,1′-carbonyldiimidazole in the presence of 
calcium hydride. Reaction of 4.11 with DMTr-protected thymidine using DBU as the 
base gave 4.12. Removal of the TBS group afforded 4.6.  
 
Scheme 4.2. Synthesis dT-Dmoc-CPG 1.1 
The dT-Dmoc linked CPG 1.1 for ODN synthesis was obtained from attaching the 
dT-Dmoc linker 4.6 to long chain alkyl amino CPG (Scheme 4.2). dT-Dmoc-linker 4.6 
was reacted with succinic anhydride. Without purification, the resulting product was 
added to CPG to react in the presence of DCC. After 2-day incubation, the CPG resin was 
capped with acetic anhydride. After washing with pyridine, methanol and acetone, the 
dT-Dmoc linker 4.6 was anchored to CPG and gave the dT-Dmoc linked CPG 1.1. The 
successful linkage could be detected by detritylation test. Because we installed the 1,3-
dithiane moiety at the side of the linkage instead of in the linkage, the construction of 1.1 
was quite simple. All the reagents used in the synthesis were inexpensive, and the yields 
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in all the steps were high. The reactions were widely used ones in organic chemistry and 
can potentially be easy to scale up. 
 
 
Figure 4.4. RP HPLC profiles of ODN 4.13 
Utilizing the dT-Dmoc-CPG 1.1, an ODN sequence 4.13 (5ʹ-TCA TTG CTG CTT 
AGA CCG CT-3ʹ) was synthesized on ABI DNA synthesizer utilizing commercially 
available nucleoside phosphoramadite reagents: Pac-dA, 4-isopropyl-Pac-dG, Ac-dC, and 
dT. The synthesis procedure and conditions were the same as those in traditional 
synthesis. The phosphoramidite concentration was 0.1 M. At the end of synthesis, DMTr 
group was kept. The trityl assay indicated a successful ODN synthesis with the new 
[min.]
Time
0 10 20 30 40 50
A
bs
 (2
60
 n
m
)
0
10
20
30
40
50
[min.]
Time
0 10 20 30 40 50
A
bs
 (2
60
 n
m
)
0
10
20
30
40
50
Crude DMTr-protected ODN 
Crude ODN 4.13 b 
a 
49 
  
linker. The overall yield was 74%. One portion of CPG was treated with ammonium 
hydroxide. The DMTr protected ODN was cleaved from CPG, which was analyzed by 
HPLC (trace a in Figure 4.4). When the ODN was detritylated, the crude ODN 4.13 was 
obtained and was shown in trace b.  
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Figure 4.5. Mechanism of the removal of β-cyanoethyl groups by DBU 
In order to cleave ODN from CPG under non-nucleophilic conditions, a group of 
oxidizing reagents such as (1S)-(+)-(10-camphorsulfonyl)oxaziridine (CSO), H2O2, meta-
chloroperoxybenzoic acid (m-CPBA) and NaIO4 were screened to oxidize Dmoc moiety 
and trigger linker cleavage. Surprisingly, we found little success with these oxidizing 
reagents. First we thought the unsuccessful cleavage was the result from failing β-
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elimination due to the absence of base. Carbonate buffer (pH 10) was mixed with NaIO4 
solution during the oxidization process. The addition of base didn’t bring any success.  
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Scheme 4.3. Two-step cleavage strategy for the cleavage of all ODN 4.14 from CPG 
The failure led us to hypothesize that the fully protected ODN was too 
hydrophobic to react with oxidants in aqueous solution such as the NaIO4 aqueous 
solution. Before deprotection, the phosphate and amino groups are protected with 
cyanoethyl groups and acetyl groups, respectively. These organic groups are hydrophobic 
and limit the solubility of ODNs in aqueous solution. To assist the oxidants such as IO4 ̵ to 
reach the linker, which is buried in the hydrophobe protected ODN layer, a phase transfer 
agent-tetrabutylammonium acetate (Bu4NOAc) was added. However, the results were 
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still very disappointing. Most oxidants failed to cleave ODN from CPG. Only the 
treatment of NaIO4 and Bu4NOAc gave small amount of ODN. To solve the solubility 
problem, another approach was designed. In hypothesis, if the cyanoethyl groups of the 
phosphate are removed, the derived ionized phosphate groups are hydrophilic and will 
greatly increase the solubility of ODN in water. The mechanism of the removale of 
cyanoethyl groups by DBU treatment was shown in Figure 4.5. 
To support our hypothesis, a 30-base-long ODN sequence (4.14, 5ʹ-TTT TTT 
TTT TTT TTT TTT TTT TTT TTT TTT TTT-3ʹ) with only deoxythymidines was 
synthesized on dT-Dmoc linked CPG 1.1. The synthesis conditions are the same as the 
synthesis of 4.13. The ODN attached to CPG only had protecting groups on phosphates. 
The cleavage was processed in two steps (Scheme 4.3).  
To remove the cyanoethyl protecting groups, CPG 4.15 was incubated with DBU, a 
strong but non-nucleophilic base, for 10 minutes. After rinsing CPG with acetonitrile and 
water sequentially, CPG 4.16 was treated with basic NaIO4 aqueous solution (mixed with 
carbonate buffer, pH 10). The resulted solution was concentrated and injected to HPLC. 
The results are shown in Figure 4.6. The 5ʹ-DMTr-protected ODN 4.17 was observed in 
HPLC (trace a) with high yield. When treating 4.16 with NaIO4 solution without 
carbonate buffer, detritylation was observed (trace b). The desired fully deprotected ODN 
4.14 was purified by HPLC (trace c).  
52 
  
  
 
Figure 4.6. RP HPLC profile of all dTs ODN 4.14 
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Scheme 4.4. Cleavage and deprotection of ODN 4.13 
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The two-step cleavage method was applied to the cleavage of ODN 4.13 (Scheme 
4.4). The ODN linked CPG 4.18 was incubated with DBU solution and sequentially with 
NaIO4 solution. The resulting ODN 4.19 aqueous solution was further treated with 
ammonium hydroxide to deprotect the exocyclic amino groups. The ODN 4.13 was 
shown at 18 minute in Figure 4.7. The ODN peak was collected, concentrated and 
analyzed by MALDI-TOF, which gave the correct molecular weight value of 4.13.  
The ability of being cleaved under both ammonium hydroxide condition and mild 
non-nucleophilic oxidative conditions made the novel dT –Dmoc linker an alternative to 
the current linking strategies for ODN synthesis. Moreover, although DBU is an organic 
base, it is non-nucleophilic. Thus, this novel Dmoc-base linker 4.6 will be useful to the 
synthesis of electrophilic functionalized ODNs. 
 
Figure 4.7. RP HPLC profile of ODN 4.13 
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4.3 Conclusion 
We have developed a novel dT-Dmoc linker for ODN synthesis. Using this linker, 
cleavage can be carried out under non-nucleophilic conditions. Therefore, the dT-Dmoc 
linker is expected to be useful for the synthesis of electrophilic ODNs. 
4.4 Experimental Section 
General Experimental 
All reactions were performed in over-dried glassware under a nitrogen 
atmosphere using standard Schlenk techniques. Reagents and solvents available from 
commercial sources were used as received unless otherwise noted. CH2Cl2, pyridine, and 
toluene were distilled over CaH2. THF was distilled over Na/benzophenone. Thin layer 
chromatography (TLC) was performed using Sigma-Aldrich TLC plates, silica gel 60F-
254 over glass support, 0.25 µm thickness. Flash column chromatography was performed 
using Selecto Scientific silica gel, particle size 32-63 µm. 1H and 13C NMR spectra were 
measured on Varian UNITY INOVA spectrometer at 400 and 100 MHz, respectively; 
chemical shifts (δ) were reported in reference to solvent peaks (residue CHCl3 at δ 7.24 
ppm for 1H and CDCl3 at δ 77.00 ppm for 13C), unless otherwise noted. High resolution 
mass spectra were obtained at Mass Spectrometry Technical Services at University of 
Michigan. 
ODNs were synthesized on a standard ABI 394 solid phase synthesizer. HPLC 
was performed on a JASCO LC-2000Plus System: pump, PU-2089Plus Quaternary 
Gradient; detector UV-2075Plus. A C-18 reverse phase analytical column (5 µm diameter, 
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100 Å, 250 × 3.20mm) was used. Solvent A: 0.1 M triethylammonium acetate, 5% 
acetonitrile. Solvent B: 90% acetonitrile. All profiles were generated by detection of 
absorbance of ODN at 260 nm using the linear gradient solvent system: solvent B (0%-
45%) in solvent A over 60min followed by solvent B (45%-100%) in solvent A over 20 
min at a flow rate of 0.5 mL/min. Lcaa-CPG (pore size 497 Å) was provided by Prime 
Synthesis, Inc., and 5ʹ-DMTr, 2-cyanoethyl phosphoramidites acetyl-dC, Pac-dA, 4-
isopropyl-Pac-dG and dT were purchased from Glen Research, Inc. D-SaltTM dextran 
desalting column (5K MWCO, 10 mL) was purchased from Pierce Biotechnology, Inc. 
O
HO N
NH
O
O
OH
DMTrCl, pyridine
r.t., 8 hr
4.9
O
DMTrO N
NH
O
O
OH
 
Compound 4.9. A round-bottom flask containing thymidine (5.000 g, 20.642 
mmol) and a magnetic stirring bar was evacuated and then refilled with nitrogen. The 
evacuation and nitrogen-filling cycle was repeated for two more times. Pyridine (75 mL) 
was added via syringe. The suspension was cooled on an ice bath. Under positive N2 
pressure, dimethoxytrityl chloride (7.344 g, 21.674 mmol) was added to the suspension 
and the reaction mixture was warmed up to room temperature and stirred overnight. 
CH2Cl2 (75 mL) and aqueous 5% NaHCO3 solution (100 mL) were added sequentially. 
The mixture was partitioned. The aqueous portion was extracted with CH2Cl2 twice. The 
organic extracts were combined and dried over anhydrous NaSO4 and filtered. After 
concentration, the crude product was purified by flash column chromatography (1:3 
hexanes/EtOAc) and compound 4.9 was obtained as a white solid (10.563 g, 94%): Rf  = 
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0.33 (hexanes/EtOAc = 1:3); 1H NMR (400 MHz, DMSO-d6) δ 1.35 (s, 3H), 1.43-1.64 
(m, 4H), 1.70-1.82 (m, 3H), 1.88-2.08 (m, 3H), 2.37-2.44 (m, 1H), 2.56-2.76 (m, 3H), 
2.84-2.93 (m, 2H), 3.42-3.51 (m, 2H), 3.61-3.65 (m, 2H), 3.77 (s, 6H), 3.97-3.99 (d, J = 
8.0 Hz, 1H), 4.24 (s, 1H), 4.97-5.02 (m, 1H), 5.34-5.35 (d, J = 4 Hz, 1H), 6.41-6.44 (dd, 
J = 4.0 Hz, 4.0 Hz, 1H), 6.81-6.83 (d, J = 8.0 Hz, 4H), 7.20-7.37 (m, 9H), 7.58 (s, 1H), 
8.78 (br s, 1H); 13C NMR (100 MHz, DMSO-d6) δ 11.4, 14.2, 21.0, 21.6, 25.4, 28.4, 28.6, 
31.6, 32.1, 38.0, 48.9, 55.2, 60.4, 62.4, 63.7, 78.7, 79.1, 83.7, 84.4, 87.2, 111.6, 113.3, 
127.2, 128.0, 128.1, 130.1, 130.1, 135.1, 135.2, 135.3, 144.2, 150.3, 154.2, 158.8, 158.8, 
163.5. 
OTBSHOHO OH
1.NaH, dry THF
0 °C to r.t., 1 hr
2. TBSCl
0 °C to r.t., 1 hr
4.7  
Compound 4.7.10 To a 250 mL 2-neck round-bottom flask, sodium hydride (60% 
dispersion in oil, 4.609 g, 115.218 mmol) and anhydrous THF (150 mL) were added. The 
suspension was cooled to 0 °C, and 1,5-pentanediol was added slowly via syringe (10 g, 
10.06 mL, 96.015 mmol). After stirring for 1 hour at room temperature, the reaction 
mixture was cooled to 0 °C, and tert-butyldimethylchlorosilane (14.472 g, 96.015 mmol) 
was added slowly. The mixture was allowed to acclimate to room temperature and stirred 
for an additional hour. The reaction was quenched with 10% aqueous K2CO3. The 
product was extracted with ether. The combined extracts were dried over anhydrous 
Na2SO4, filtered and concentrated. Flash column chromatography (3:1 hexanes/EtOAc) 
gave compound 4.7 as colorless oil (12.806 g, 61%): Rf  = 0.34 (hexanes/EtOAc = 3:1, 
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dark purple spot with 5% H2SO4 stain solution); 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 
6H), 0.90 (s, 9H), 1.37-1.45 (m, 2H), 1.52-1.63 (m, 4H), 1.71 (br s, 1H), 3.61-3.67 (m, 
4H); 13C NMR (100 MHz, CDCl3) δ -5.6, 18.0, 21.7, 25.6, 32.1, 62.5, 62.8; HRMS (ESI) 
m/z calcd for C11H27O2Si [M+H]+ 219.1775, found 219.1777.  
OTBS
O
HOTBSHO
(COCl)2, DMSO, CH2Cl2
-78  °C, 1.5 hr
4.7 4.8  
Compound 4.8.10 A solution of oxalyl chloride (3.252 g, 2.20 mL, 25.617 mmol) 
in dry CH2Cl2 (15 mL) was cooled to -78 °C under N2. A solution of DMSO (4.003 g, 
3.64 mL, 51.234 mmol) in CH2Cl2 (15 mL) was added dropwise. After stirring for 5 min, 
a solution of tert-butyldimethylsiloxyl pentanol 4.7 (5.595 g, 25.617 mmol) in CH2Cl2 
(20 mL) was added dropwise, and the resulting mixture was stirred for 15 min. Then 
Et3N (12.961 g, 14 mL, 128.961 mmol) was added slowly. After stirring for another 10 
minutes at -78 °C, the cooling bath was removed and the reaction was allowed to warm to 
ambient temperature for 1 hour. The reaction was quenched with water (15 mL). After 
stirring for 15 minutes, the reaction mixture was separated by separatory funnel and the 
organic layer was successively washed with aqueous 5% HCl, saturated NaHCO3 
solution, and brine. The organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated. Flash column chromatography (19:1 hexanes/EtOAc) gave compound 4.8 
as colorless oil (5.148 g, 93%): Rf  = 0.28 (hexanes/EtOAc =19:1, dark blue spot with 
vanillin stain solution) ; 1H NMR (400 MHz, CDCl3) δ 0.00 (s 6H), 0.85 (s, 9H), 1.47-
1.54 (m, 2H), 1.62-1.70 (m, 2H), 2.39-2.43 (dt, J = 8 Hz, 1.6 Hz, 2H), 3.57-3.60 (t, J = 6 
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Hz, 2H), 9.72 (s, 1H); 13C NMR (100 MHz, CDCl3) δ -5.4, 18.2, 18.6, 25.9, 32.1, 43.5, 
62.5, 202.5; HRMS (ESI) m/z calcd for C11H25O2Si [M+H]+ 217.1624, found 217.1609.   
HO
S S
OTBS
1. t-BuLi, THF
-78  °C to -10  °C, 1.5 hr
2. 4.8, THF
-78  °C, 15 min
S S
4.10  
Compound 4.10. A solution of 1,3-dithiane (3.254 g, 27.060 mmol) in dry THF 
(50 mL) was cooled to -78 °C under N2. A solution of tert-butyllithium (1.7 M in pentane, 
16.0 mL, 27.060 mmol) was added dropwise. After addition, the reaction mixture was 
allowed to warm to -40 °C and stayed at the temperature for 1 hour. The reaction mixture 
was cooled back to -78 °C, and a solution of tert-butyldimethylsiloxyl pentanal 4.8 
(4.880 g, 22.550 mmol) in dry THF (30 mL) was added slowly via canula. The reaction 
mixture was allowed to react for 15 minutes, and then quenched with saturated NH4Cl 
solution (50 mL). The mixture was allowed to warm up to ambient temperature. The 
organic layer was separated and the aqueous layer was extracted by EtOAc. The 
combined organic layer was washed with water and brine. The organic layer was dried 
over anhydrous Na2SO4, filtered and concentrated. Flash column chromatography (9:1 
hexanes/EtOAc) gave compound 4.10 as colorless oil (5.402 g, 71%): Rf  = 0.2 
(hexanes/EtOAc=9:1) ; 1H NMR (400 MHz, CDCl3) δ 0.02 (s, 6H), 0.86 (s, 9H), 1.38-
1.48 (m, 1H), 1.49-1.59 (m, 4H), 1.77-1.84 (s, 1H), 1.89-1.98 (s, 1H), 2.01-2.10 (s, 1H), 
2.43 (d, J = 3,6 Hz, 1H), 2.68-2.78 (m, 2H), 2.86-2.94 (m, 2H), 3.59 (t, J = 10.4 Hz, 2H), 
3.80-3.85 (m, 1H), 3.87-3.89(d, J = 6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 
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22.1, 25.7, 26.0, 28.0, 28.5, 32.6, 33.8, 52.5, 63.0, 72.2; HRMS (ESI) m/z calcd for 
C15H33O2S2Si [M+H]+ 337.1686, found 337.1695.  
O
S S
OTBSN
O
NHO
S S
OTBS N N
O
N N
, CaH2, toluene
r.t., 8 hr
4.114.10  
Compound 4.11. A mixture of carbonyldiimidazole (2.606 g, 16.071 mmol), 
compound 4.10 (2.164 g, 6.428 mmol), CaH2 (90% grade, 0.752 g, 16.071 mmol) and dry 
toluene (100 mL) was stirred at room temperature overnight.  The reaction mixture was 
filtered and concentrated.  After flash column chromatography (3:1 hexanes/EtOAc), 
compound 4.11 was obtained as colorless sticky oil (2.833 g, 100%): Rf  = 0.2 
(hexanes/EtOAc =3:1); 1H NMR (400 MHz, CDCl3) δ 0.01 (s, 6H), 0.82 (s, 9H), 1.39-
1.56 (m, 5H), 1.80-2.08 (m, 5H), 2.67-2.78 (m, 2H), 2.84-2.95 (m, 2H), 3.56-3.58 (t, J = 
4 Hz, 2H), 4.10-4.11 (d, J = 4 Hz, 1H), 5.28-5.33 (m, 1H), 7.04 (s, 1H), 7.40 (s, 1H), 8.12 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ -5.4, 18.2 21.7, 25.4, 25.8, 28.4, 28.6, 31.4, 32.2, 
48.9, 62.4, 78.4, 117.2, 130.6, 137.2, 148.3; HRMS (ESI) m/z calcd for C19H35N2O3S2Si 
[M+H]+ 431.1853, found 431.1858.  
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Compound 4.12. A mixture of compound 4.9 (3.721 g, 6.833 mmol), compound 
4.11 (1.962 g, 4.555 mmol) and DBU (0.208 g, 0.20 mL, 1.367 mmol) in dry toluene (50 
mL) was stirred at room temperature for 8 hours. The reaction mixture was concentrated 
on a rotary evaporator and purified with flash column chromatography (hexanes/EtOAc = 
3:1, 0.5% Et3N). Compound 4.12 was obtained as a white foam (3.140 g, 76%): M. P. = 
81.2-82.6 °C; Rf = 0.45 (hexanes/EtOAc = 1:1); 1H NMR (400 MHz, CDCl3) δ (TMS as 
the reference) 0.00 (s, 6H), 0.84 (s, 9H), 1.31 (s, 3H), 1.36-2.00 (m, 11H), 2.34-2.74 (m, 
5H), 2.80-2.89 (m, 2H), 3.41-3.47 (m, 2H), 3.55-3.59 (t, J = 8 Hz, 2H), 3.75 (s, 6H), 
3.93-3.95 (d, J = 8 Hz, 1H), 4.20 (s, 1H), 4.91-4.96 (m, 1H), 5.34-5.36 (d, J = 8 Hz, 1H), 
6.40-6.44 (dd, J = 4 Hz, 8 Hz, 1H), 6.78-6.80 (d, J = 8 Hz, 4H), 7.18-7.34 (m, 9H), 7.54 
(s, 1H), 8.08 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ -5.3, 11.6, 18.3, 21.7, 25.4, 26.0, 
28.4, 28.6, 31.6, 32.3, 37.9, 48.9, 55.3, 62.7, 63.7, 78.8, 78.9, 84.0, 84.3, 87.2, 111.5, 
113.3, 127.2, 128.0, 128.1, 130.1, 135.2, 135.3, 135.4, 144.2, 150.0, 154.3, 158.8, 163.3; 
HRMS (ESI) m/z calcd for C47H62N2O10S2SiNa [M+Na]+ 929.3507, found 929.3497. 
O
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0  °C to r.t., 8 hrO
O
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O
S S
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4.12 4.6  
dT-Dmoc-Linker 4.6. To a THF (40 mL) solution of compound 4.12 (1.470 g, 
1.620 mmol) at 0 °C, TBAF (1.95 mL, 1.0 M in THF) was added dropwise. The reaction 
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mixture was warmed to room temperature and stirred overnight. The mixture was 
partitioned between EtOAc (40 mL) and H2O (40 mL). The aqueous layer was extracted 
with EtOAc twice. The combined organic layers were dried over anhydrous Na2SO4, 
filtered and concentrated. Flash column chromatography (hexanes/EtOAc=1:1) gave 
compound 4.6 as a white foam (0.958 g, 75%): TM = 90.6-92.3 °C;  Rf = 0.3 
(hexanes/EtOAc = 1:3); 1H NMR (400 MHz, CDCl3) δ 1.35 (s, 3H), 1.41-1.63 (m, 4H), 
1.69-1.81 (m, 3H), 1.89-2.08 (m, 4H), 2.37-2.44 (m, 1H), 2.56-2.75 (m, 3H), 2.84-2.93 
(m, 2H), 3.42-3.51 (m, 2H), 3.61-3.65 (m, 2H), 3.77 (s, 6H), 3.97-3.99 (d, J = 8 Hz, 1H), 
4.24 (s, 1H), 4.97-5.01 (m, 1H), 5.34-5.35 (d, J = 4 Hz, 1H), 6.41-6.44 (dd, J = 4 Hz, 8 
Hz), 6.81-6.83 (d, J = 8 Hz, 4H), 7.20-7.37 (m, 9H), 7.58 (s, 1H), 8.78 (s, 1H); 13C NMR 
(100 MHz, CDCl3) δ 11.6, 14.2, 21.0, 21.6, 25.4, 28.4, 28.6, 31.6, 32.1, 38.0, 48.9, 55.2, 
60.4, 62.4, 63.7, 78.7, 79.1, 83.7, 84.4, 87.2, 111.6, 113.3, 127.2, 128.0, 128.1, 130.1, 
130.1, 135.1, 135.2, 135.3, 144.2, 150.3, 154.2, 158.8, 158.8, 163.5; HRMS (ESI) m/z 
calcd for C41H48N2O10S2Na [M+Na]+ 815.2643, found 815.2636.  
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O
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2, DCC, NH2
CPG
, DMF
3, Acetic anhydride, DMAP, pyridine
r.t., 8 hr
r.t. 2 d
1.14.6  
dT-Dmoc-CPG 1.1.11 A mixture of Dmoc-dT linker 4.6 (0.100 g, 0.126 mmol), 
succinic anhydride (0.050 g, 0.504 mmol), and DMAP (0.031 g, 0.252 mmol) in 
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anhydrous pyridine (3 mL) was stirred at room temperature. After 2 days, the mixture 
was partitioned between EtOAc (5 mL) and H2O (5 mL). The organic layer was washed 
with saturated aqueous NaHCO3 and brine, dried over anhydrous Na2SO4 and 
concentrated. The residue was dissolved in dry DMF (3 mL). To the solution, amino-
lcaa-controlled pore glass (0.251 g, 0.027 mmol, 107 µM/g, 497 Å, Prime Synthesis, Inc.) 
and DCC (0.027 mL, 1.0 M in CH2Cl2) was added. The mixture was kept at room 
temperature for 2 days. After the resin was washed with pyridine, 5 mL of a capping 
solution (0.1 M DMAP in pyridine:Ac2O, 9:1, v/v) was added, and the whole mixture 
was kept at room temperature for 2 days. The resin was subsequently washed with 
pyridine, MeOH, DMF and acetone, and was dried under vacuum.  
 
ODN synthesis, cleavage, deprotection and analysis 
5ʹ-TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT-3ʹ (4.14) 
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 30-mer ODN was 
synthesized on an ABI DNA/RNA synthesizer at 1 µmol scale. 5ʹ-DMTr-protected 2-
cyanoethyl dT phosphoramidite monomer was used for the synthesis. 
THF/pyridine/Pac2O was used as the capping reagent. The manufacturer recommended 
synthetic cycle was followed. Manual cleavage and DMTr on functions were chosen. 
After synthesis, the CPG was dried, weighed and equally distributed into 10 vials.  
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Cleavage. One portion of CPG (7.3 mg) was suspended with a solution of DBU 
in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. The supernatant 
was pipetted out and the CPG was washed with dry CH3CN three times (200 µL each 
time) and also washed with DI-H2O three times (200 µL each time). To the CPG, a 
NaIO4 aqueous solution (0.05M, 1000µL) was added. After the incubation at room 
temperature with rotating for 3 hours, the supernatant was transferred to an Eppendorf 
tube. The CPG was washed with deionized water three times (200 µL each time). The 
combined aqueous solution was desalted over a dextran desalting column (5K MWCO, 
10 mL) with the DI-H2O as eluent. Fractions were collected every milliliter. Fractions 3, 
4, 5, 6 were combined and concentrated. The ODN was dissolved in 200 µL H2O, and 20 
µL solution was injected into RP HPLC. ODN 4.14 was shown in Figure 4.6. 
 
5ʹ-TCA TTG CTG CTT AGA CCG CT-3ʹ (4.13) 
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 20-mer was 
synthesized on an ABI DNA/RNA synthesizer at 1 µmol. The following 5ʹ-DMTr-
protected 2-cyanoethyl phosphoramidite monomers were used for the synthesis: Pac-dA, 
4-isopropyl-Pac-dG, Ac-dC, and dT. THF/pyridine/Pac2O was used as the capping 
reagent. The manufacturer recommended synthetic cycle was followed. Manual cleavage 
and DMTr on functions were chosen. After synthesis, the CPG was dried, weighed and 
evenly distributed into 10 vials. 
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Cleavage and deprotection. One portion of CPG (4.2 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, a NaIO4 aqueous solution (0.05M, 1000µL) was added. After 
the incubation at room temperature with rotating for 3 hours, the supernatant was 
transferred to an Eppendorf tube. The CPG was washed with deionized water three times 
(200 µL each time). The combined aqueous solution was concentrated. To the residue, 28% 
NH3 aqueous solution (1000 µL) was added. The resulting solution was votexed and kept 
at room temperature for 8 hours. After concentration, the resulted mixture was dissolved 
in 200 µL H2O, and 20 µL solution was injected into RP HPLC. ODN 4.13 was shown in 
Figure 4.7. MALDI-TOF cald mass 6059, found 6058.594. 
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Chapter 5  
Synthesis of Dmoc-protected Phophoramidite Monomers and Their 
Applications in ODN Synthesis1 
Abstract 
Dmoc protected phosphoramidites were synthesized and used to synthesize ODNs 
along with the dT-Dmoc linker. The deprotection and cleaveage of ODNs from CPG was 
achieved under non-nucleophilic conditions. 
5.1 Introduction 
The chemical synthesis of ODN has made a great contribution to the biological 
study and biomedical application of nucleic acids. The most commonly used synthetic 
strategy is phophoramadite chemistry. One key element to have an efficient ODN 
synthesis is to have a good protecting group scheme. The protecting scheme should allow 
the selective removal of a specific protecting group at a desired time. To make matters 
more challenging, the protecting groups must be removable almost quantitatively. 
Otherwise, the yield of desired product will be low and the product itself may be 
irresolvable from contaminants. Furthermore, purines are susceptible to depurination 
under mildly to acidic conditions. Hence strong acids should be avoided. 
1 The contents of Chapter 5 were adapted into a journal paper “Oligonucleotide Synthesis 
Using Protecting Groups and a Linker Cleavable under Non-nucleophilic Conditions”. 
This paper has been submitted to the Chemical Communication for peer review. 
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Three functional groups need to be protected: 1) the 5ʹ hydroxyl groups; 2) the 
exocyclic amino groups; 3) the phosphates.  
The most common protecting groups for 5ʹ hydroxyl group is the trityl group 
(Figure 5.1), which was reported by Khorana et al..1 The combination of good stability 
and easiness for removal with mild acid has made it superior over others. The reason that 
the trityl family cleaves so readily under acidic conditions lies in the formation of 
carbocations. The trityls have distinctive colors when ionized, which have made them 
extremely useful as diagnostic tools. The dimethoxytrityl (DMTr) carbocation has a very 
strong orange color in mild acid. It has a high extinction coefficient that can still be 
accurately measured using optical approach even at very low concentrations. The 
monomethoxytrityl (MMTr) carbocation has a yellow color, while the parent trityl (Tr) 
itself is deep red. The efficiency of each cycle of nucleoside addition can be followed by 
measuring the absorbance of the released DMTr groups.  
O OO
Trityl Cation
Red
Monomethoxytrityl Cation
Yellow
Dimethoxytrityl Cation
Orange  
Figure 5.1. The trityl family 
Khorana also introduced the protecting groups for the exocyclic amino groups of 
nucleosidic bases. They are isobutyryl for guanosine and benzoyl for adenosine and 
cytidine (Figure 5.2). To date, they are known as standard protecting groups.2 Acetyl-
protected cytidine is also widely used in ODN synthesis. The removal of these acyl 
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groups is carried out with strong nucleophiles, such as concentrated ammonium 
hydroxide. 
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R R
R R
N-Benzoyl Cytidine N-Acety Cytidine
N-Benzoyl Adenosine N-Isobutyryl Guanosine  
Figure 5.2. Standard protecting groups for nucleoside bases 
Phosphate moieties are usually protected by β-cyanoethyl groups. These groups 
were introduced by Letsinger on phosphite chemistry and later adapted by Caruthers on 
phosphoramidites.3 With base-induced β-elimination, the deprotection of β-cyanoethyl 
groups can be simply achieved with strong bases which are also required for deprotecting 
exocyclic amino acyl protecting groups. 
However, the ODN synthesis methods utilizing conventional protecting groups is 
not compatible with some modified ODN syntheses, especially those ODNs with 
electrophilic functionalities. β-Cyanoethyl group can be removed by non-nucleophilic 
bases, such as DBU.4 However the deprotection of exocyclic amino groups needs strong 
nucleophiles. So far, there are two strategies to synthesize such electrophilic ODN 
analogues. One methodology is to use nucleosidic phosphoramidites without base 
protection.4-5 Sekine and his coworkers have proposed a method using activated 
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phosphite (Figure 5.3); where they activated phosphoramidite 5.1 with 1-
hydroxybenzotriazole (HOBt).5b The derived triester 5.3 can be highly selective with the 
5ʹ hydroxyl group of 5.2. However these methods have to be customized to each specific 
modification and cannot be universally applied on all electrophilic ODN syntheses. 
Moreover, the method has low coupling yields, and therefore cannot be used to 
synthesize long ODNs. 
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Figure 5.3.  Sekine’s activated phosphite method 
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Another strategy is to investigate on protecting groups which can be removed 
under mild conditions. However the functionalities in organic chemistry suitable for this 
need are limited. Hazawa and his coworkers have reported an allylic protection method 
for modified ODN synthesis.6 In the protocol, they protected the internucleotide linkages 
with allylic groups and nucleoside bases with allyloxycarbonyl groups. The modified 
ODNs can be obtained after deprotection by treating with a mixture of Pd(0) complexes, 
triphenylphosphine, butylamine and fomic acid. However the application of Pd(0) 
complexes has resulted in the difficulties of complete removal of Pd(0) and high reagent 
cost. 
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Figure 5.4. Allylic protecting groups for ODN synthesis 
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In this chapter, we report Dmoc-based protecting groups for nucleoside 
phosphoramidites (1.2-1.4, Figure 5.5) which can be removed under non-nucleophilic 
conditions with cost effective oxidizing reagents. The combination of these Dmoc-
protected phosphoramidites and dT-Dmoc linker shall provide a universal method for 
electrophilic ODN synthesis. 
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Figure 5.5. Dmoc-protected nucleoside phosphoramidite monomers 
5.2 Results and Discussion 
As shown in Scheme 5.2, the Dmoc moieties were introduced to nucleosidic bases 
using Dmoc precursor 5.10, which was produced from the convertion of dithianyl ethanol 
5.9 with p-nitrochloroformate (Scheme 5.1).  
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54% 87%  
Scheme 5.1. Synthesis of Dmoc protecting group precursor 
The exo-amino groups of DMTr protected dC (5.11) and dA (5.13) were 
conveniently protected using (1,3-dithian-2-yl)methyl 4-nitrophenyl carbonate (5.10) by 
first protecting the 3′-hydroxyl group with trimethylsilyl chloride (TMSCl) temporarily 
followed by stirring the reactants at room temperature with DMAP as the catalyst. The 
products 5.12 and 5.14 were obtained in 100% and 57% yields, respectively. When the 
same acylation method was applied to synthesize the Dmoc protected dG 5.18, no desired 
product could be isolated. 
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Scheme 5.2. Synthesis of Dmoc protected dC and dA 
After testing several conditions for the synthesis of 5.18, we realized this was a 
difficult task. However we knew that we could solve the problem. It only took time. The 
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more challenging problem to be solved is the application of the Dmoc protected 
phosphoramidites and Dmoc-linker for ODN synthesis under non-nucleophilic 
conditions. As a result we decided to put the synthesis of 5.18 aside and forwarded to 
synthesize Dmoc-dC-amidite 1.2 and Dmoc-dA-amidite 1.3 (Scheme 5.3).  
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Scheme 5.3. Synthesis of Dmoc-dC-amidite and Dmoc dA-amidite 
Phosphinylation of 5.12 and 5.14 using 2-cyano-N,N,N′,N′- 
tetraisopropylphosphordiamidite gave the ODN synthesis phosphoramidite monomers 
Dmoc-dC-amidite 1.2 and Dmoc-dA-amidite 1.3, respectively in excellent yields. 
With dT-Dmoc-CPG 1.1 and the phosphoramidite monomers 1.2 and 1.3, we 
synthesized an ODN sequence without dG (5.16, 5ʹ-HO-TTA CTT CTA TTA TCA ATC 
CT-OH-3ʹ). The synthesis procedure and conditions were the same as those in traditional 
ODN synthesis using the phosphoramidite chemistry. The phosphoramidite concentration 
was 0.1 M. At the end of synthesis, DMTr group was kept on the ODN sequence. 
According to trityl assay, the coupling steps have high efficiency with an average step-
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wise yield of 98% and an overall yield of 69%, which showed no negative affect by using 
the dT-Dmoc-linker and Dmoc-protected phosphoramidites.  
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Scheme 5.4. The cleavage and deprotection of ODN 5.16 
 
Figure 5.6. HPLC profile of ODN 5.16 
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The cleavage and deprotection of ODN 5.16 is shown in Scheme 5.4. The 2-
cyanoethyl groups were removed by treating 5.15 with DBU. The sulfide functions of 
Dmoc moieties were then oxidized with NaIO4 aqueous solution. Followed with β-
elimination, ODN 5.16 was obtained, which was analyzed by HPLC (Figure 5.6) and 
MALDI-TOF. 
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Scheme 5.5. Synthesis of Dmoc-dG-amidite 
After the feasibility of ODN synthesis using Dmoc phosphoramidites and Dmoc-
linker is established, we came back to solve the problem of syntheisizng Dmoc-protected 
dG 5.18. The challenge of acylating dG could be attributed to the lower nucleophilicity of 
the exo-amino group on dG (pKa of conjugate acid 3.2) compared to those on dC (pKa of 
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conjugate acid 4.4) and dA (pKa of conjugate acid 4.1).7 It is also possible that the 
acylation reaction occurred but the carboxyamide bond was broken during NH4OH 
treatment in the procedure for removal of TMS groups used for temporary protecting 3̓-
OH. Based on these hypotheses, the procedure was modified (Scheme 5.5). Instead of 
using DMTr protected nucleoside, dG was used directly. The two hydroxyl groups were 
temporarily protected with TMS, and the acylation reaction was carried out with 10 
equivalents of 5.10. The intermediate 5.17 was not isolated, and the TMS groups were 
removed by HF-pyridine. All volatiles were then evaporated with a nitrogen flow over 
the surface of the reaction mixture. The residue (5.17) was reacted with DMTrCl directly 
to give 5.18 in 14% yield after flash column chromatography. Phosphinylation of 5.18 
using 2-cyano-N,N,N′,N′- tetraisopropylphosphordiamidite gave Dmoc-dG-amidite 1.4 in 
excellent yield.  
With dT-Dmoc-CPG 1.1 and all phosphoramidite monomers 1.2-1.4, we 
synthesized another four ODN sequences. They were 5ʹ-OH-TCA TTG CTT CTG ATC 
CTG CT-3ʹ (5.19), 5ʹ-HO-TCA TTG CTG CTT ATA CCT CT-OH-3ʹ (5.20), 5ʹ-HO-
TCA TTG CTG CTT AGA CCG CT-OH-3ʹ (5.21) and 5ʹ-HO-TTA GTA GGA CCT 
ACA CCT GT-OH-3ʹ (5.22). The syntheses of ODNs followed the synthesis of 5.16. 
According to trityl assay, high yields were achieved for each ODN sequence (overall 
yield: 82% for 5.19, 77% for 5.20, 79% for 5.21 and 78% for 5.22). The same cleavage 
and deprotection process of ODN 5.16 was applied for the retrieve of these ODNs. To 
our surprise, multiple peaks instead of one peak were observed, such as ODN 5.19 in 
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trace a in Figure 5.7. 
 
 
Figure 5.7. RP HPLC profile of ODN 5.19 from the unsuccessful deprotection 
We repeated the experiments twice, and HPLC profiles were identical. The 
extracts had been passed through a polyacrylamide desalting column (6 K MWCO). 
Small molecules have been excluded by the desalting process. The peaks shown should 
be from large molecules. There was no ODN shown from the final ammonia cleavage of 
the residual CPG. The multiple peaks must be from ODNs in an unexpected forms. From 
our previous studies, we knew that ODN is stable under the used oxidizing conditions. 
These peaks should not be oxidatively damaged ODNs. From our group’s ODN 
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purification project, we have found similar peak pattern for ODNs, which was caused by 
the reaction of ODNs with Michael acceptors through conjugate addition.8  We believed 
that similar conjugate addition might have happened in the cleavage and deprotection 
process of ODNs. Nucleophilic sites of the full-length ODN reacted with 5.23, which is a 
side product from Dmoc deprotection, through conjugate addition (Scheme 5.6). If this is 
true, the conjugation adducts should be able to convert back to unmodified ODNs by 
removing the Michael acceptor moieties. Based on this hypothesis, the fractions of HPLC 
containing the ODNs from the multiple peaks were collected through HPLC. After 
concentration, the substrates were treated with concentrated NH4OH at 80 C̊ for 1 hour, 
and analyzed with HPLC. As shown in in Figure 5.7 (trace b), the multiple peaks merged 
in to one peak. This observation supported our hypothesis. The reason that we didn’t 
observe ODN conjugates from HPLC profiles of ODN 5.16, might be due to the 
differences of the nucleophilicity of nucleoside bases. Comparing to dA, dT and dC, dG 
is more reactive toward nucleophiles which is also the main cause of DNA alkylation.9  
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5.23   
Scheme 5.6.  Michael acceptor-an addcut from the removal of Dmoc protecting group 
To avoid the Michael addition of Dmoc derivatives to ODNs, the Michael 
acceptor must be scavenged. Since our purpose is to synthesize electrophilic 
functionalized ODNs, the scavenger we tempt to introduce into the system should be mild 
enough to be compatible with electrophilic ODNs. The choices left to us were very 
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limited. Aniline became the best candidate for this task. Aniline is a moderate 
nucleophiles and weak base. The pKa of aniline is 4.19. Any functionality that is not 
stable to aniline is not expected to be stable toward ODN itself. Moreover, there are many 
other nucleophiles stronger than aniline existing in living system. Incorporation of 
functionalities that are unstable toward aniline is not expected to be stable for in vivo 
study. The use of aniline in our procedure will not be a concern for electrophilic ODN 
synthesis.  Further, the weak basity of aniline can help to induce the β-elimination of the 
Dmoc group after the sulfides are oxidized to sulfoxides.  
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Scheme 5.7. Cleavage and deprotection of ODN 5.19 
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However another issue came out. The incubation of CPG with aniline and NaIO4 
gave lots of brownish precipitates. We later found out that the precipitates were from the 
reaction of aniline with NaIO4. To avoid the side reaction, we decided to use a 2-step 
process for deprotection and cleavage: 1) oxidization; 2) β-elimination/scavenging step. 
From previous studies, NaIO4 itself can oxidize sulfide and at the same time induce β-
elimination to remove the Dmoc moieties. To limit the chances of removing Dmoc 
moieties, we introduced acetic acid into the oxidizing process to prevent β-elimination. 
After incubating with acetic NaIO4 solution at pH 2 and washing with acetic acid solution 
(0.5M in water, pH 2), the CPG anchored with ODNs 5.24, of which sulfides on Dmoc 
groups have been oxidized, was treated with aniline solution at pH 8. Since the Michael 
reaction between aniline and Michael acceptor is reversible especially while 
concentrating, a D-SaltTM dextran column (5 K MWCO) was used to remove the small 
molecules such as Michael addition adducts and extra aniline. The crude ODN 5.19 was 
purified with RP HPLC. The profiles of crude and purified 5.19 are shown in Figure 5.8. 
The MALDI-TOF analysis result of pure 5.19 indicated correct structure. From the 
extract of oxidation process, no cleaved/deprotected ODN was found in trace c, which 
suggested successful restriction of β-elimination by acetic acid. The treatment of residual 
CPG with concentrated NH4OH gave little ODN in trace d. This indicates the cleavage of 
ODN was efficient. 
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Figure 5.8. RP HPLC profiles of ODN 5.19 from the successful deprotection 
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 Figure 5.8. Cont’d 
The two step strategy for the removal of Dmoc moieties was applied to the 
cleavage/deprotection of other three ODNs (5.20, 5.21 and 5.22). The profiles of crude 
and purified 5.20-5.22 are shown in Figure 5.9. All the ODNs were analyzed with 
MALDI-TOF MS, which indicated correct structure. One thing interesting was that the 
pure ODN 5.22 (a short piece of HIV protease gene) gave a peak with a small shoulder 
(trace f). While running ODN 5.22 sample with HPLC at 60 ̊C, the shoulder disappeared 
in trace g. It is known that oligonucleotides with two successive Gs are capable of 
forming four-stranded helical structures called G-quadruplexes.10 The oddity we found 
might also be caused by the formation of G-quadruplexes.  
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Figure 5.9. HPLC profiles of ODN 5.20-5.22 
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Figure 5.9. Cont’d 
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 Figure 5.9. Cont’d 
The Dmoc based linker and protecting groups are ideal for electrophilic ODN 
synthesis. Before oxidation, H-2 in the function is not acidic in normal terms of organic 
chemistry (pKa ~31), which enables Dmoc to be completely stable during ODN 
synthesis. After oxidation, the pKa of H-2 is lowered to ~12. Compared to the Fmoc 
amino protecting group, in which case the pKa of H-9 is ~22, and the group can be 
removed by the weak base piperidine (pKa of conjugate acid ~11), the Dmoc linker and 
protecting group were predicted to be readily cleavable under nearly neutral and 
nonnucleophilic conditions. Our results have shown that this is indeed the case. 
Compared to the ODN synthesis methods that used the allyl and o-nitrobenzyl 
functionalities for protection and linking, the Dmoc method does not require any 
expensive transition metal and UV light for deprotection and cleavage. Instead, the 
readily available and easily removable NaIO4 and aniline can accomplish the complex 
task.  
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5.3 Conclusion 
We have developed a new ODN synthesis method using the Dmoc function as 
protecting groups. Along with the application of dT-Dmoc linker, we successfully 
synthesized the ODNs with the deprotection and cleavage method which is carried out 
under non-nucleophilic conditions. Therefore, this new method shall enable the synthesis 
of electrophilic ODN analogues 
5.4 Experimental Section 
General Experimental 
All reactions were performed in over-dried glassware under a nitrogen 
atmosphere using standard Schlenk techniques. Reagents and solvents available from 
commercial sources were used as received unless otherwise noted. CH2Cl2, pyridine, 
toluene were distilled over CaH2, and THF was distilled over Na. Thin layer 
chromatography (TLC) was performed using Sigma-Aldrich TLC plates, silica gel 60F-
254 over glass support, 0.25 µm thickness. Flash column chromatography was performed 
using Selecto Scientific silica gel, particle size 32-63 µm. 1H, 13C and 31P NMR spectra 
were measured on Varian UNITY INOVA spectrometer at 400, 100 and 162 MHz, 
respectively; chemical shifts (δ) were reported in reference to solvent peaks (residue 
CHCl3 at δ 7.24 ppm for 1H and CDCl3 at δ 77.00 ppm for 13C and H3PO4 at δ 0.00ppm 
for 31P), unless otherwise noted. High resolution mass spectra were obtained at Mass 
Spectrometry Technical Services at University of Michigan. 
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ODNs were synthesized on a standard ABI 394 solid phase synthesizer. MALDI-
TOF mass spectra were obtained on a Bruker Microflex LRF spectrometer. HPLC was 
perfomed on a JASCO LC-2000Plus System: pump, PU-2089Plus Quaternary Gradient; 
detector UV-2075Plus. A C-18 reverse phase analytical column (5 µm diameter, 100 Å, 
250 × 3.20mm) was used. Solvent A: 0.1 M triethylammonium acetate, 5% acetonitrile. 
Solvent B: 90% acetonitrile. All profiles were generated by detection of absorbance of 
ODN at 260 nm using the linear gradient solvent system: solvent B (0%-45%) in solvent 
A over 60min followed by solvent B (45%-100%) in solvent A over 20 min at a flow rate 
of 0.5 mL/min. Lcaa-CPG (pore size 497 Å) was sponsored by Prime Synthesis, Inc., and 
5ʹ-DMTr, 2-cyanoethyl phosphoramidites acetyl-dC, Pac-dA, 4-isopropyl-Pac-dG and dT 
were purchased from Glen Research, Inc. D-SaltTM dextran desalting column (5K 
MWCO, 10 mL) was purchased from Pierce Biotechnology, Inc. MIX = 
Et2O/MeCN/MeOH/Et3N = 5:2:2:1 
S
S
OH
5.9
S S
 t-BuLi, THF
-78  °C to -10  °C, 1.5 hr
then (CH2O)n
-78  °C to r.t., 3 hr
 
(1,3-Dithian-2-yl)methanol 5.9. A solution of dithiane (10.000 g, 83.167 mmol) 
in THF (50 mL) was cooled at -78 °C. t-BuLi (1.7 M in pentane, 58.7 mL, 99.800 mmol) 
was added dropwise. The reaction mixture was allowed to acclimate to -10 °C and stay at 
the temperature for 1 hour. The mixture was cooled back to -78 °C and was transferred 
slowly to a solution of paraformaldehyde (7.492 g, 249.500 mmol) in THF (50 mL) at -
78 °C. The whole mixture was allowed to acclimate to room temperature and stirred for 3 
90 
 
hours. The mixture was partitioned between EtOAc and saturated NH4Cl solution. The 
aqueous layer was extracted with EtOAc (50 mL × 2). The combined organic layer was 
dried over anhydrous Na2SO4, filtered and concentrated. Flash column chromatography 
(2:1 hexanes/Et2O) gave compound 5.9 as pale yellow oil (6.749 g, 54%): Rf = 0.35 
(hexanes/ Et2O = 1:1, brown spot with I2 stain); 1H NMR (400 MHz, CDCl3) δ 1.88-2.03 
(m, 2H), 2.58-2.63 (m, 3H), 2.82-2.86 (m, 2H), 3.77-3.86 (m, 3H); 13C NMR (100 MHz, 
CDCl3) δ 25.4, 26.5, 46.1, 63.0; HRMS (EI) m/z calcd for C5H10OS2 [M]+ 150.0173, 
found 150.0171.  
NO2O
O
O
S
S
5.10
S
S
OH
5.9
NO2O
O
Cl
, pyridine
0 °C to r.t., 8 hr
 
Compound 5.10. While cooled on an ice bath, to a solution of dithianylmethanol 
(2.499 g, 16.66 mmol) in pyridine (30 mL) was slowly added 4-nitrobenzyl 
chloroformate (3.694 g, 18.326 mmol). The reaction mixture was left to stir at room 
temperature. After 8 hours, the mixture was kept in freezer for 1 hour, and then was 
quenched with cold 10% HCl solution. The mixture was extracted with EtOAc. After the 
separation, the organic layer was washed sequentially with cold 10% HCl solution, H2O 
and brine. The resulted organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated. After recrystallization from EtOAc/hexanes, compound 5.10 was obtained 
as white crystals (4.588 g, 87%): M. P. = 79.2-81.6 °C; Rf = 0.25 (hexanes/EtOAc = 1:1); 
1H NMR (400 MHz, CDCl3) δ 2.02-2.08 (m, 2H), 2.68-3.01 (m, 4H), 4.08-4.12 (t, J = 8 
Hz, 1H), 4.59-4.61 (d, J = 8 Hz, 2H), 7.37-7.41 (m, 2H), 8.25-8.29 (m, 2H); 13C NMR 
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(100 MHz, CDCl3) δ 25.2, 26.9, 42.0, 68.3, 121.8, 125.3, 145.4, 152.3, 155.4; HRMS 
(EI) m/z calcd for C12H13NO5S2 [M] + 315.0235, found 315.0239. 
O
OH
HO N
N
NH2
O
DMTrCl, pyridine
r.t., 8 hr
O
OH
DMTrO N
N
NH2
O
5.11  
Compound 5.11. A round-bottom flask containing deoxycytidine (0.500 g, 2.201 
mmol) and a magnetic stirring bar was evacuated and then refilled with nitrogen. The 
evacuation and nitrogen-filling cycle was repeated for two more times. Pyridine (15 mL) 
was added and a suspension was formed. The suspension was cooled on an ice bath. 
Under positive N2 pressure, dimethoxytrityl chloride (0.820 g, 2.421 mmol) was added to 
the suspension and the reaction mixture was stirred while warming up to room 
temperature gradually. After 8 hours, CH2Cl2 and 5% NaHCO3 solution were added. The 
mixture was partitioned. The aqueous portion was extracted with CH2Cl2 (15 mL × 2). 
The extracts were combined and dried over anhydrous Na2SO4. After concentration, the 
crude product was purified by flash column chromatography (1:2:1 hexanes/EtOAc/MIX) 
and compound 5.11 was obtained as a white solid (0.952 g, 82%): Rf  = 0.23 
(hexanes/EtOAc/MIX = 1:2:3); M. P. = 114.4-116.3 °C, 1H NMR and 13C NMR data can 
be found in literature11; HRMS (ESI) m/z calcd for C30H32N3O6 [M+H]+ 530.2286, found 
530.2293. 
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OH
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HN
O
1. TMSCl, pyridine
r.t., 0.5 hr
2, 5.10, DMAP, pyridine
r.t., 8 hr
3. 28% aq. NH4OH
r.t., 0.5 hr
O
O
S
S
5.11 5.12  
Compound 5.12. A solution of dimethoxyltrityl deoxycytidine 5.11 (2.598 g, 
4.915 mmol) and chlorotrimethylsilane (1.602 g, 1.87 mL, 14.744 mmol) in pyridine (50 
mL) was stirred at room temperature. After 30 minutes, a solution of compound 5.10 
(3.100 g, 9.830 mmol) and DMAP (0.300 g, 2.457 mmol) in pyridine (15 mL) was added 
to the reaction mixture. The whole mixture was left to stir for 8 hours. The reaction 
mixture was cooled on an ice bath, quenched with H2O (10 mL) and stirred for 5 minutes. 
28% NH4OH aqueous solution (15 mL) was added and the whole was stirred for an 
additional 30 minutes. The whole mixture was washed with 5% NaHCO3 aqueous 
solution. The aqueous layer was extracted with CH2Cl2 (30 mL × 2). The extracts were 
dried over anhydrous Na2SO4, filtered and concentrated. Flash column chromatography 
(1:2:1 hexanes/EtOAc/MIX) gave compound 5.12 as a white foam (4.022 g, 100%): M. 
P. = 121.1-123.4 °C, Rf  = 0.32 (hexanes/EtOAc/MIX = 1:2:1); 1H NMR (400 MHz, 
CDCl3) δ 1.93-2.09 (m, 2H), 2.21-2.27 (m, 1H), 2.41 (br s, 1H), 2.62-2.96 (m, 5H), 3.37-
3.41 (m, 2H), 3.79 (s, 6H), 4.07-4.10 (t, J = 6Hz, 1H), 4.46-4.48 (m, 3H), 6.21-6.24 (t, J 
= 6Hz, 1H), 6.82-6.84 (d, J = 8 Hz, 4H), 6.96 (d,  J = 8 Hz, 1H), 7.20-7.39 (m, 9H), 8.22-
8.24 (d, J = 8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.4, 27.3, 41.9, 42.8, 55.2, 62.6, 
65.6, 70.7, 86.3, 86.9, 113.2, 127.0, 128.0, 128.1, 130.0, 135.3, 135.4, 135.4, 144.2, 
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158.6, 162.1; HRMS (ESI) m/z calcd for C36H40N3O8S2 [M+H] 706.2251, found 
706.2249. 
O
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Compound 1.2. A round-bottom flask containing 5.12 (0.695 g, 0.987 mmol), 
and a magnetic stirring bar was evacuated and then refilled with nitrogen. The evacuation 
and nitrogen-filling cycle was repeated for two more times. Dry CH2Cl2 (10 mL) and 2-
cyanoethyl-N,N,Nʹ,Nʹ-tetraisopropylphosphoramidite (0.327 g, 0.34 mL, 1.086 mmol) 
were added via syringes. A 1H-tetrazole solution in CH3CN (0.45 M, 2.413 mL, 1.086 
mmol) was added via a syringe in one portion. After stirring at room temperature for 2 
hours, the reaction mixture was concentrated to dryness by blowing N2 to the surface. 
The residue was purified with flash column chromatography (1:1 hexane/EtOAc) giving 
compound 1.2 as a white foam (0.800 g, 89%): Rf = 0.32(hexanes/EtOAc = 1:3); 1H 
NMR (400 MHz CDCl3) δ 1.12-1.15 (t, J = 6 Hz, 12H), 1.90-2.07 (m, 2H), 2.24-2.30 (m, 
1H), 2.39-2.43 (t, J = 8 Hz, 2H), 2.64-2.71 (m, 3H), 2.88-2.93 (m, 2H), 3.35-3.57 (m, 
6H), 3.77 (s, 6H), 4.17-4.18 (m, 1H), 4.44-4.46 (d, J = 8 Hz, 2H), 4.57-4.64 (m, 1H), 
6.20-6.23 (t, J = 6 Hz), 6.81-6.88 (m, 5H), 7.22-7.38 (m, 9H), 8.26-8.28 (d,  J = 8 
Hz ,1H); 13C NMR (100 MHz, CDCl3) δ 20.1, 24.6, 27.2, 29.9, 40.8, 42.7, 43.3, 55.2, 
58.1, 58.3, 61.9, 65.6, 71.6, 85.6, 86.8, 94.5, 113.2, 117.3, 127.0, 127.9, 128.2, 129.6, 
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130.0, 130.1, 135.2, 135.3, 144.0, 144.3, 158.6, 162.0; 31P NMR (162 MHz, CDCl3) δ 
150.4. 
N
NN
N
NH2
O
OH
HO
DMTrCl, pyridine
r.t., 8 hr
N
NN
N
NH2
O
OH
DMTrO
5.13  
Compound 5.13. A round-bottom flask containing deoxyadenosine (0.853 g, 
3.168 mmol) and a magnetic stirring bar was evacuated and then refilled with nitrogen. 
The evacuation and nitrogen-filling cycle was repeated for two more times. Pyridine (10 
mL) was added and a suspension was formed. The resulting suspension was cooled on an 
ice bath. Under positive N2 pressure, dimethoxytrityl chloride (1.073 g, 3.168 mmol) was 
added to the suspension and the reaction mixture was stirred while warming up to room 
temperature gradually. After 8 hours, CH2Cl2 (10 mL) and 5% NaHCO3 solution (15 mL) 
was added. The mixture was partitioned. The aqueous portion was extracted with CH2Cl2 
(10 mL × 2). The extracts were combined, dried over anhydrous Na2SO4 and filtered. 
After concentration, the crude product was purified by flash column chromatography 
(1:2:1 hexanes/EtOAc/MIX) and compound 5.13 was obtained as a white solid (1.211 g, 
69%): Rf  = 0.42 (hexanes/EtOAc/MIX = 1:2:3); M. P. = 83.7-85.5 °C, 1H NMR and 13C 
NMR data can be found in literature11; HRMS (ESI) m/z calcd for C31H32N5O5 [M+H]+ 
554.2398, found 554.2408. 
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Compound 5.14. A solution of dimethoxyltrityl deoxyadenosine 5.13 (0.208 g, 
0.376 mmol) and chlorotrimethylsilane (0.082 g, 0.096 mL, 0.751 mmol) in pyridine (4 
mL) was stirred at room temperature. After 30 minutes, a solution of compound 5.10 
(0.237 g, 0.751 mmol) and DMAP (0.091 g, 0.751 mmol) in pyridine (3 mL) was added 
to the reaction mixture. The whole mixture was left to stir for 8 hours. The reaction 
mixture was cooled on an ice bath, quenched with H2O (2 mL) and stirred for 5 minutes. 
28% NH4OH aqueous solution (3 mL) was added and the whole was stirred for additional 
30 minutes. The whole mixture was washed with 5% NaHCO3 solution. The aqueous 
layer was extracted with CH2Cl2 twice. The combined organic layer was dried over 
anhydrous Na2SO4, filtered and concentrated. Flash column chromatography (1:2:1 
hexanes/EtOAc/MIX) gave compound 5.14 as a white foam (0.175 g, 57%): M. P. = 
108.2-111.4 °C; Rf  = 0.47 (Hexanes/EtOAc/MIX = 1:2:1); 1H NMR (400 MHz, CDCl3) 
δ 1.89-2.04 (m, 2H), 2.50-2.97 (m, 6H), 3.34-3.39 (d, J = 4 Hz, 2H), 3.72 (s, 6H), 4.09-
4.16 (m.1H), 4.16-4.19 (m, 1H), 4.52-4.53 (d, J = 4 Hz, 2H), 4.68-4.71 (m, 1H), 6.44-
6.47 (t, J = 6 Hz, 1H), 6.73-6.75 (d, J = 8Hz, 4H), 7.12-7.35 (m, 9H), 8.13 (s, 1H), 8.66 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 25.4, 27.3, 40.2, 43.0, 55.2, 65.3, 72.2, 84.6, 
86.2, 86.5, 113.1, 122.3, 126.9, 135.5, 141.4, 149.2, 158.4; HRMS (ESI) m/z calcd for 
C37H40N5O7S2 [M+H]+ 730.2364, found 730.2366. 
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Compound 1.3. A round-bottom flask containing 5.14 (1.180 g, 1.555 mmol), 
and a magnetic stirring bar was evacuated and then refilled with nitrogen. The evacuation 
and nitrogen-filling cycle was repeated for two more times. Dry CH2Cl2 (10 mL) and 2-
cyanoethyl-N,N,Nʹ,Nʹ-tetraisopropylphosphoramidite (0.515 g, 0.54 mL, 1.710 mmol) 
were then added via syringes. A 1H-tetrazole solution in CH3CN (0.45 M, 3.8 mL, 1.71 
mmol) was added via a syringe in one portion. After stirring at room temperature for 2 
hours, the reaction mixture was concentrated to dryness by blowing nitrogen to the 
surface. The residue was purified with flash column chromatography 
(hexanes/EtOAc/Et3N = 1:1:1) giving compound 1.3 as a white foam (1.271 g, 88%): Rf 
= 0.4 (hexanes/EtOAc/Et3N = 1:1:1); 1H NMR (400 MHz CDCl3) δ 1.15-1.18 (t, J = 6 
Hz, 12H), 1.94-2.07 (m, 2H), 2.52-2.99 (m, 6H), 3.31-3.43 (m, 2H), 3.55-3.72 (m, 4H), 
3.76 (s, 6H), 4.11-4.15 (t, J = 8 Hz, 1H), 4.28-4.31 (m, 1H), 4.55-4.57 (d, J = 8 Hz, 2H), 
4.74-4.79 (m, 1H), 6.43-6.46 (t, J = 6 Hz, 1H), 6.76-6.78 (d, J = 8 Hz, 4H), 7.16-7.37 (m, 
9H), 8.16 (s, 1H), 8.68 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 20.4, 20.5, 24.7, 24.8, 
25.7, 39.7, 43.2, 43.4, 55.4, 63.5, 65.6, 73.6, 73.8, 85.0, 86.2, 86.3, 86.7, 113.3, 117.6, 
122.7, 127.1, 128.0, 128.4, 130.3, 135.8, 135.8, 141.7, 144.7, 149.5, 150.8, 151.1, 152.9, 
158.7; 31P NMR (162 MHz, CDCl3) δ 150.0. 
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Compound 5.18. Deoxyguanosine monohydrate (0.159 g, 0.595 mmol) was 
coevaporated with dry pyridine three times (2 mL pyridine each time). The dry 
deoxyguanosine was suspended in dry pyridine (6 mL). The suspension was cooled on an 
ice bath and chlorotrimethylsilane (0.651 g, 0.76 mL, 5.931 mmol) was added. The 
mixture was stirred for 15 minutes. Nitrobenzyl dithianyl carbonate 5.10 (1.870 g, 5.931 
mmol) and DMAP (0.072 g, 0.593 mmol) were added to the reaction mixture. The 
mixture was stirred at room temperature for 8 hours. Under positive nitrogen pressure, 
HF/pyridine (70%, 0.215 mL, 11.862 mmol) was added into the reaction mixture via a 
pipett. After stirring for 20 minutes, the reaction mixture was concentrated by blowing 
with nitrogen on the mixture surface. The resulting mixture was dissolved with EtOAc (5 
mL) and washed with H2O (5 mL). The organic layer was concentrated and coevaporated 
with dry pyridine three times (2 mL pyridine each time). The residue was redissolved 
with dry pyridine (5 mL) and DMTrCl (0.161 g, 0.476 mmol) was added. The reaction 
mixture was stirred at room temperature for 8 hours. The reaction was quenched with 5% 
NaHCO3 and the mixture was partitioned. The aqueous layer was extracted by EtOAc. 
The combined organic layer was dried over anhydrous Na2SO4, filtered and concentrated. 
Flash column chromatography (9:1 EtOAc/MeOH) gave compound 5.18 as a white foam 
(0.060 g, 14%): M. P. = 159 – 161 °C; Rf = 0.2 (EtOAc/MeOH = 9:1); 1H NMR (400 
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MHz, CDCl3) δ 1.94-2.06 (m, 2H), 2.48-2.59 (m, 2H), 2.63-2.96 (m, 4H), 3.27-3.41 (m, 
2H), 3.68 (s, 6H), 4.08-4.12 (t, J = 8 Hz, 1H), 4.15-4.18 (m, 1H), 4.56-4.58 (d, J = 8 Hz, 
2H), 4.87-4.91 (m, 1H), 6.20-6.23 (t, J = 6 Hz, 1H), 6.67-6.70 (dd, J = 9 Hz, 3 Hz, 4H), 
7.07-7.33 (m, 9H), 7.68 (s, 1H);13C NMR (100 MHz, CDCl3) δ 10.8, 14.2, 25.4, 27.0, 
40.1, 42.6, 45.8, 55.2, 60.4, 64.3, 65.7, 71.7, 84.3, 86.4, 86.5, 113.0, 120.9, 126.8, 135.7, 
144.5, 148.4, 154.4, 155.8, 158.4; HRMS (ESI) m/z calcd for C37H40N5O8S2 [M+H]+ 
746.2313, found 746.2311. 
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Compound 1.4. A round-bottom flask containing 5.18 (0.601 g, 0.821mmol), and 
a magnetic stirring bar was evacuated and then refilled with nitrogen. The evacuation and 
nitrogen-filling cycle was repeated for two more times. Dry CH2Cl2 (6 mL) and 2-
cyanoethyl-N,N,Nʹ,Nʹ-tetraisopropylphosphoramidite (0.272 g, 0.29 mL, 0.903 mmol) 
were then added via syringes. A 1H-tetrazole solution in CH3CN (0.45 M, 2.0 mL, 0.903 
mmol) was added via a syringe in one portion. After stirring at room temperature for 2 
hours, the reaction mixture was concentrated to dryness by blowing nitrogen to the 
surface. The residue was purified with flash column chromatography (1:1 
hexanes/EtOAc) giving compound 1.4 as a white foam (0.600 g, 77%): Rf = 0.5 
(EtOAc/MeOH = 29:1); 1H NMR (400 MHz CDCl3) δ 1.12-1.15 (m, 12H), 1.97-2.03 (m, 
2H), 2.32-2.95 (m, 8H), 3.33-3.34 (d, J = 4 Hz, 2H), 3.51-3.63 (m, 4H), 3.73 (s, 6H), 
3.93-3.98 (t, J = 10 Hz, 1H), 4.24-4.47 (m, 1H), 4.49-4.51 (d, J = 8 Hz, 2H), 4.68-4.74 
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(m, 1H), 6.17-6.20 (t, J = 6 Hz, 1H), 6.73-6.76 (m, 4H), 7.13-7.38 (m, 9H), 7.74 (s, 1H); 
13C NMR (100 MHz, CDCl3) δ 20.2, 20.3, 24.5, 24.5, 24.6, 26.8, 39.4, 42.1, 43.2, 43.3, 
55.2, 57.8, 58.0, 63.7, 65.6, 73.7, 73.8, 84.6, 86.0, 86.3, 113.1, 117.3, 121.7, 126.9, 127.8, 
128.0, 130.0, 135.7, 137.5, 144.5, 146.2, 148.0, 153.0, 158.5; 31P NMR (162 MHz, 
CDCl3) δ 149.4. 
 
ODN synthesis, deprotection, cleavage and analysis 
5ʹ-HO-TTA CTT CTA TTA TCA ATC CT-OH-3ʹ (5.16) 
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 20-mer was 
synthesized on an ABI DNA/RNA synthesizer at 1 µmol scale.. The following 5ʹ-DMTr-
protected 2-cyanoethyl phosphoramidite monomers were used for the synthesis: Dmoc-
dA 1.3, Dmoc-dC 1.2, and dT. THF/pyridine/Pac2O was used as the capping reagent. The 
manufacturer recommended synthetic cycle was followed. Manual cleavage and DMTr 
on functions were chosen. After synthesis, the CPG was dried, weighed and evenly 
distributed into 10 vials. 
Cleavage and deprotection. One portion of CPG (4.3 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, a NaIO4 aqueous solution (0.1 M, 1mL DI-H2O) was added. 
The suspension was covered with aluminum foil and left to rotate for 3 hours. The 
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supernatant was transferred to an Eppendorf tube. The CPG was washed with deionized 
water three times (200 µL each time). The supernatant was transferred to an Eppendorf 
tube. The CPG was washed with deionized water three times (200 µL each time). The 
combined aqueous solution was desalted over dextran desalting column (5K MWCO, 10 
mL) with DI-H2O as the eluent. Fractions were collected every milliliter. Fractions 3, 4, 
5, 6 were combined and concentrated. The obtained ODN was dissolved in 50 µL H2O, 
and 20 µL solution was injected into RP HPLC. ODN 5.16 was shown in Figure 5.6.  
MALDI-TOF MS calcd mass 5993, found 5992.3. 
 
5ʹ-HO-TCA TTG CTT CTG ATC CTG CT-OH-3ʹ (5.19) 
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 20-mer was 
synthesized on an ABI DNA/RNA synthesizer at 1 µmol scale.. The following 5ʹ-DMTr-
protected 2-cyanoethyl phosphoramidite monomers were used for the synthesis: Dmoc-
dA 1.3, Dmoc-dG 1.4, Dmoc-dC 1.2, and dT. THF/pyridine/Pac2O was used as the 
capping reagent. The manufacturer recommended synthetic cycle was followed. Manual 
cleavage and DMTr on functions were chosen. After synthesis, the CPG was dried, 
weighed and evenly distributed into 10 vials. 
Cleavage and deprotection. One portion of CPG (4.3 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, an acidic NaIO4 aqueous solution (0.1 M, 970 µL DI-H2O, 
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30 µL AcOH, pH = 2) was added. The suspension was covered with aluminum foil and 
left to rotate for 3 hours. The supernatant was transferred to an Eppendorf tube. The CPG 
was washed with acidic deionized water three times (3% AcOH, v/v, 200 µL each time). 
To the resin was added an aniline aqueous solution (3% aniline, v/v, 1000 µL). After the 
suspension rotated for 8 hours, the supernatant was transferred to an Eppendorf tube. The 
CPG was washed with deionized water three times (200 µL each time). The combined 
aqueous solution was desalted over dextran desalting column (5K MWCO, 10 mL) with 
DI-H2O as the eluent. Fractions were collected every milliliter. Fractions 3, 4, 5, 6 were 
combined and concentrated. The obtained ODN was dissolved in 50 µL H2O, and 20 µL 
solution was injected into RP HPLC. ODN 5.19 was shown in Figure 5.8.  MALDI-TOF 
MS calcd mass 6025, found 6024.0. 
 
5ʹ-HO-TCA TTG CTG CTT ATA CCT CT-OH-3ʹ (5.20) 
Synthesis. The CPG with Dmoc-dT linker 1 (50 mg, 5.35 µmol) with a pore size 
of 497 Å was packed in a standard DNA synthesis column. The 20-mer was synthesized 
on an ABI DNA/RNA synthesizer at 1 µmol scale. The following 5ʹ-DMTr-protected 2-
cyanoethyl phosphoramidite monomers were used for the synthesis: Dmoc-dA 1.3, 
Dmoc-dG 1.4, Dmoc-dC 1.2, and dT. THF/pyridine/Pac2O was used as the capping 
reagent. The manufacturer recommended synthetic cycle was followed. Manual cleavage 
and DMTr on functions were chosen. After synthesis, the CPG was dried, weighed and 
evenly distributed into 10 vials. 
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Cleavage and deprotection. One portion of CPG (4.3 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, an acidic NaIO4 aqueous solution (0.1 M, 970 µL DI-H2O, 
30 µL AcOH, pH = 2) was added. The suspension was covered with aluminum foil and 
left to rotate for 3 hours. The supernatant was transferred to an Eppendorf tube. The CPG 
was washed with acidic deionized water three times (3% AcOH, v/v, 200 µL each time). 
To the resin was added an aniline aqueous solution (3% aniline, v/v, 1000 µL). After the 
suspension rotated for 8 hours, the supernatant was transferred to an Eppendorf tube. The 
CPG was washed with deionized water three times (200 µL each time). The combined 
aqueous solution was desalted over dextran desalting column (5K MWCO, 10 mL) with 
DI-H2O as the eluent. Fractions were collected every milliliter. Fractions 3, 4, 5, 6 were 
combined and concentrated. The obtained ODN was dissolved in 50 µL H2O, and 20 µL 
solution was injected into RP HPLC. ODN 5.20 was shown in Figure 5.9. MALDI-TOF 
MS calcd mass 6009, found 6008.193. 
 
5ʹ-HO-TCA TTG CTG CTT AGA CCG CT-OH-3ʹ (5.21) 
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 20-mer was 
synthesized on an ABI DNA/RNA synthesizer at 1 µmol scale. The following 5ʹ-DMTr-
protected 2-cyanoethyl phosphoramidite monomers were used for the synthesis: Dmoc-
dA 1.3, Dmoc-dG 1.4, Dmoc-dC 1.2, and dT. THF/pyridine/Pac2O was used as the 
103 
 
capping reagent. The manufacturer recommended synthetic cycle was followed. Manual 
cleavage and DMTr on functions were chosen. After synthesis, the CPG was dried, 
weighed and evenly distributed into 10 vials. 
Cleavage and deprotection. One portion of CPG (5.4 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, an acidic NaIO4 aqueous solution (0.1 M, 970 µL DI-H2O, 
30 µL AcOH, pH = 2) was added. The suspension was covered with aluminum foil and 
left to rotate for 3 hours. The supernatant was transferred to an Eppendorf tube. The CPG 
was washed with acidic deionized water three times (3% AcOH, v/v, 200 µL each time). 
To the resin was added an aniline aqueous solution (3% aniline, v/v, 1000 µL). After the 
suspension rotated for 8 hours, the supernatant was transferred to an Eppendorf tube. The 
CPG was washed with deionized water three times (200 µL each time). The combined 
aqueous solution was desalted over dextran desalting column (5K MWCO, 10 mL) with 
DI-H2O as the eluent. Fractions were collected every milliliter. Fractions 3, 4, 5, 6 were 
combined and concentrated. The obtained ODN was dissolved in 50 µL H2O, and 20 µL 
solution was injected into RP HPLC. ODN 5.21 was shown in Figure 5.9. MALDI-TOF 
MS calcd mass 6059, found 6058.594. 
 
5ʹ-HO-TTA GTA GGA CCT ACA CCT GT-OH-3ʹ (5.22)  
Synthesis. The CPG with Dmoc-dT linker 1.1 (50 mg, 5.35 µmol) with a pore 
size of 497 Å was packed in a standard DNA synthesis column. The 20-mer was 
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synthesized on an ABI DNA/RNA synthesizer at 1 µmol scale. The following 5ʹ-DMTr-
protected 2-cyanoethyl phosphoramidite monomers were used for the synthesis: Dmoc-
dA 1.3, Dmoc-dG 1.4, Dmoc-dC 1.2, and dT. THF/pyridine/Pac2O was used as the 
capping reagent. The manufacturer recommended synthetic cycle was followed. Manual 
cleavage and DMTr on functions were chosen. After synthesis, the CPG was dried, 
weighed and evenly distributed into 10 vials. 
Cleavage and deprotection. One portion of CPG (5.2 mg) was suspended with a 
solution of DBU in dry CH3CN (10%, v/v, 500 µL), and was hand shaken for 10 minutes. 
The supernatant was pipetted out and the CPG was washed with CH3CN three times (200 
µL each time). To the CPG, an acidic NaIO4 aqueous solution (0.1 M, 970 µL DI-H2O, 
30 µL AcOH, pH = 2) was added. The suspension was covered with aluminum foil and 
left to rotate for 3 hours. The supernatant was transferred to an Eppendorf tube. The CPG 
was washed with acidic deionized water three times (3% AcOH, v/v, 200 µL each time). 
To the resin was added an aniline aqueous solution (3% aniline, v/v, 1000 µL). After the 
suspension rotated for 8 hours, the supernatant was transferred to an Eppendorf tube. The 
CPG was washed with deionized water three times (200 µL each time). The combined 
aqueous solution was desalted over dextran desalting column (5K MWCO, 10 mL) with 
DI-H2O as the eluent. Fractions were collected every milliliter. Fractions 3, 4, 5, 6 were 
combined and concentrated. The obtained ODN was dissolved in 50 µL H2O, and 20 µL 
solution was injected into RP HPLC. ODN 5.22 was shown in Figure 5.9.  MALDI-TOF 
MS calcd mass 6092, found 6089.606. 
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Chapter 6 
Improved Synthesis of Dmoc-dG-amidite1 
Abstract 
An improved protocol for the synthesis of Dmoc-dG-amidite is described. The 
step for acylation of dG was accomplished in fair to good yields. The advantages of the 
new protocol include much less starting materials, greener conditions and higher yield. 
The novel synthetic strategy is expected to be widely useful for the acylation of the exo-
amino groups on nucleoside bases.  
6.1 Introduction 
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Figure 6.1. Dmoc-dG-amidite 1.4 
Latent electrophilic ODNs are expected to have great potentials as therapeutics 
and diagnostic probes.1 However the synthesis of such ODN analogues has been 
extremely difficult. Due to the strongly nucleophilic conditions used for deprotection and 
cleavage, current ODN synthesis technology is not suitable for the synthesis of 
1 The contents in Chapter 6 will be revised and be submitted to the Tetrahedron Letters. 
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electrophilic ODNs. Many attempts have been made to avoid strong nuclephiles in ODN 
synthesis, such as utilizing photo-labile groups, allyloxyl groups.  
We have reported our own solution to the synthesis of electrophilic ODNs in 
previous chapters. We synthesized Dmoc-protected nucleoside phosphoramidite 
monomers and dT-Dmoc-CPG, and successfully applied these compounds in ODN 
synthesis. By removing Dmoc moieties under oxidizing conditions, we provided a 
universal deprotection/cleavage method for ODN synthesis using non-nucleophilic 
conditions. However, for our method to be practically useful, the yield of synthesizing 
1.4 (Figure 6.1) has to be improved. Although we were pleased at the initial 14% yield in 
our reported synthesis of 1.4, we knew that it needed to be improved if we were going to 
advance our technology to practical use. Moreover, in our initial studies, the introduction 
of Dmoc group to dG required excess dithianyl-nitrobenzyl formate 5.10 (10 equivalent). 
If we can reduce the starting material, we can make our synthesis greener and reduce the 
working load. In this chapter, we describe our efforts on developing a more efficient 
protocol for the synthesis of Dmoc-dG-amidite 1.4. 
6.2 Results and Discussion 
Our first effort on improving the synthesis procedure for Dmoc-dG-amidite is 
shown in Scheme 6.1. Deoxyguanosine was first protected with tetraisopropyldisiloxyl 
groups in quantitative yield. The protected deoxyguanosine derivative 6.1 was reacted 
with tert-butyl magnesium chloride in THF in the presence of HMPA. The introduction 
of Dmoc group to dG moiety was achieved by the reaction of the Grignard derivative 
with 5.10 and gave 6.2 in 44% yield. This procedure reduced the loading of 5.10 from 10 
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equivalents to 2.5 equivalents. However the successful synthesis lies on the addition of 
HMPA, which is highly toxic, has a high boiling poin, and very painful to remove with 
common organic chemistry techniques. 
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Scheme 6.1. Method A of introducing dG with Dmoc group 
To avoid the issues caused by HMPA, we developed another method shown in 
Scheme 6.2. We treated 6.1 with tert-butyl lithium. The resulting anion was reacted with 
chlorotrimethysilane chloride. The intermediate 6.3 was deprotonated with tert-butyl 
lithium, and reacted with 5.10. The acylated compound 6.2 was obtained in 40 % yield. 
The reaction mixture only gave 2 dots on TLC plates, which greatly reduce the labor 
needed for purification.   
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Scheme 6.2 Method B of introducing dG with Dmoc group 
The silyl-type protecting groups are usually removed by fluoride,2 such as 
hydrogen fluoride (HF) and tetrabutylammonium fluoride (TBAF). Because HF is more 
toxic, TBAF is usually preferred. We developed a new way of applying HF to remove 
tetraisopropyldisiloxyl group (Scheme 6.3). Compound 6.2 was treated with excess 
HF/pyridine. The siloxyl groups were removed. The extra HF was quenched with 
methoxytrimethylsilane and the resulted products such as methol and trimethylsilane 
fluoride and extra methoxytrimethylsilane were simply removed by rotary evaporation 
due to their low boiling points. Without purification, the resulting mixture was reacted 
with DMTrCl and gave 5.18 in 80% yield. Phophorylation of 5.18 was accomplished by 
2-cyano-N,N,N′,N′- tetraisopropylphosphordiamidite. Dmoc-dG-amidite 1.4 was obtained 
in 77% yield. 
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1. HF/Pyridine, pyridine, r.t., 2 hr,
 then methoxytrimethylsilane, r.t. 8 hr
2. DMTrCl, pyridine
r.t., 8 hr
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Scheme 6.3. Synthesis of Dmoc-dG-amidite 1.4 
6.3 Conclusion 
An improved synthetic protocol for the synthesis of Dmoc-dG-amidite was 
developed. This protocol might be used as a generally applicable strategy for the 
acylation of nucleoside bases. 
6.4 Experimental Section 
General Experimental 
All reactions were performed in over-dried glassware under a nitrogen 
atmosphere using standard Schlenk techniques. Reagents and solvents available from 
commercial sources were used as received unless otherwise noted. CH2Cl2, pyridine, 
toluene were distilled over CaH2, and THF was distilled over Na. Thin layer 
chromatography (TLC) was performed using Sigma-Aldrich TLC plates, silica gel 60F-
254 over glass support, 0.25 µm thickness. Flash column chromatography was performed 
using Selecto Scientific silica gel, particle size 32-63 µm. 1H and 13C spectra were 
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measured on Varian UNITY INOVA spectrometer at 400, 100 and 162 MHz, respectively; 
chemical shifts (δ) were reported in reference to solvent peaks (residue CHCl3 at δ 7.24 
ppm for 1H and CDCl3 at δ77.00 ppm for 13C), unless otherwise noted. High resolution 
mass spectra were obtained were obtained at Mass Spectrometry Technical Services at 
University of Michigan. 
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Compound 6.1. Deoxyguanosine monohydrate (6.000 g, 21.040 mmol) was 
coevaporated with pyridine three times (10 mL each time) and was suspended in 
anhydrous DMF (50 mL) with imidazole (5.729 g, 23.142 mmol). To the suspension, 1,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane (7.300 g, 23.142 mmol) was added dropwise. 
The reaction mixture was stirred at room temperature for 2 hours. The resulting mixture 
was partitioned between EtOAc and H2O. The organic layer was dried over anhydrous 
Na2SO4, filtered and concentrated. Column chromatography (9:1 CHCl3/MeOH) gave 
compound 6.1 (10.611 g, 99%) as a white solid. M.P. > 285 °C (dec.); Rf = 0.37 
(CHCl3/MeOH = 9:1); 1H NMR (400 MHz, DMSO-d6) δ 0.86-1.11 (m, 28H), 2.41-2.63 
(m, 2H), 3.72-3.76 (m, 1H), 3.83-3.92 (m, 2H), 4.61-4.66 (m, 1H), 6.01-6.04 (m, 1H), 
6.43 (s, 2H), 7.79 (s, 1H), 10.61 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δ 12.7, 12.9, 
13.2, 13.4, 17.5, 17.6, 17.6, 17.7, 17.9, 18.0, 62.8, 71.6, 81.5, 85.1, 117.3, 135.2, 151.3, 
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154.4, 157.3; HRMS (ESI) m/z calcd for C22H40N5O5Si2 [M+H]+: 510.2562, found 
[M+H]+ 510.2560. 
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Compound 6.2 made using either method A or B (see below). M.P. 130-132 °C; 
Rf = 0.3 (CHCl3/MeOH = 19:1); 1H NMR (400 MHz, CDCl3) δ 0.99-1.09 (m, 28H), 2.00-
2.07 (m, 2H), 2.53-2.56 (m, 2H), 2.66-2.99 (m, 2H), 3.83-4.11 (m, 4H), 4.53-4.62 (m, 
2H), 4.68-4.74 (m, 1H), 6.09-6.11 (m, 1H), 7.85 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
12.7, 13.2, 13.3, 13.6, 17.1, 17.2, 17.3, 17.4, 17.5, 17.6, 25.5, 27.1, 40.3, 42.5, 62.0, 66.1, 
70.0, 82.8, 85.4, 121.8, 136.9, 146.3, 153.0, 155.6; HRMS (ESI) m/z calcd for 
C28H48N5O7S2Si2 [M+H]+: 686.2528, found [M+H]+ 686.2535. 
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Method A: To a solution of tetraisopropyldisiloxane-diyl deoxyguanosine 6.1 
(2.555 g, 5.037 mmol) in HMPA (5 mL) and THF (50 mL) was added dropwise tert-
butylmagnesium chloride (1 M in THF, 15.1 mL, 15.101 mmol) at -78 °C. The reaction 
was allowed to acclimate to room temperature and stirred for 30 minutes. The reaction 
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mixture was cooled back to -78 °C, and was added a solution of nitrobenzyl dithianyl 
carbonate 5.10 (3.971 g, 12.592 mmol) and DMAP (1.538 g, 12.591 mmol) in THF (25 
mL) slowly. After stirring for 8 hours at room temperature, the reaction mixture was 
quenched with MeOH (8 mL) and concentrated. The resulting residue was redissolved 
with EtOAc and washed sequentially with 0.15 M EDTA, saturated NaHCO3 aqueous 
solution and brine. The organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated. Column chromatography (19:1 CHCl3/MeOH) gave compound 6.2 (1.528 g, 
44 %) as a white solid.  
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Method B: Tetraisopropyldisiloxane-diyl deoxyguanosine 6.1 (1.100 g, 2.168 
mmol) and nitrobenzyl dithianyl carbonate (0.821g, 2.602 mmol) was put in a desiccator 
and dried over fresh drierite under high vacuum overnight. The dry deoxyguanosine 
derivative was added to a two neck round bottom flask, and dry THF (15 mL) was added. 
To the solution of deoxyguanosine derivative was slowly added tert-butyllithium solution 
(1.7 M in pentane, 1.53 mL, 2.602 mmol) at -78 °C. The reaction mixture was allowed to 
warm up to -10 °C and stay at the temperature for one hour. Then the mixture was cooled 
back to -78 °C, and was added chlorotrimethylsilane (0.283 g, 2.602 mmol). The reaction 
mixture was allowed to warm up to room temperature and stir for one hour. The mixture 
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was cooled back to -78 °C, and was added a THF (15 mL) solution of dry nitrobenzyl 
dithianyl carbonate 5.10 slowly. The whole mixture was acclimate to room temperature 
and was left to stir for 8 hour. The reaction mixture was partitioned between EtOAc and 
H2O. The organic layer was dried over anhydrous Na2SO4, filtered and concentrated. 
Column chromatography (19:1 CHCl3/MeOH) gave compound 6.2 (0.581 g, 40 %) as a 
white solid. 
1. HF/Pyridine, pyridine, r.t., 2 hr,
 then methoxytrimethylsilane, r.t. 8 hr
2. DMTrCl, pyridine
r.t., 8 hr
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Compound 5.18.  To a solution of deoxyguanosine derivative 6.2 (0.569 g, 0.832 
mmol) in dry pyridine (10 mL) was added HF/pyridine (70%, 0.357 g, 12.477 mmol) at 
0 °C. After 2 hours, methoxyltrimethylsilane (1.300 g, 12.477 mmol) was added. The 
whole reaction mixture was stirred for 8 hours. The reaction mixture was concentrated 
and coevaporated with dry pyridine three times (5 mL each time). The residue was 
dissolved with dry pyridine (20 mL). Under positive N2 pressure, dimethoxytrityl 
chloride (0.282 g, 0.832 mmol) was added to the solution. The whole mixture was left to 
stir for 8 hours. The reaction mixture was partitioned between CH2Cl2 and 5% NaHCO3 
aqueous solution. The organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated. After column chromatography (9:1 EtOAc/MeOH), compound 5.18 (1.062 
g, 80%) was obtained as a white foamy solid. M.P. 159 – 161 °C; Rf = 0.2 
(EtOAc/MeOH = 9:1); 1H NMR (400 MHz, CDCl3) δ 1.94-2.06 (m, 2H), 2.48-2.59 (m, 
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2H), 2.63-2.96 (m, 4H), 3.27-3.41 (m, 2H), 3.68 (s, 6H), 4.08-4.12 (t, J = 8 Hz, 1H), 
4.15-4.18 (m, 1H), 4.56-4.58 (d, J = 8 Hz, 2H), 4.87-4.91 (m, 1H), 6.20-6.23 (t, J = 6 Hz, 
1H), 6.67-6.70 (dd, J = 9 Hz, 3 Hz, 4H), 7.07-7.33 (m, 9H), 7.68 (s, 1H);13C NMR (100 
MHz, CDCl3) δ 10.8, 14.2, 25.4, 27.0, 40.1, 42.6, 45.8, 55.2, 60.4, 64.3, 65.7, 71.7, 84.3, 
86.4, 86.5, 113.0, 120.9, 126.8, 135.7, 144.5, 148.4, 154.4, 155.8, 158.4; HRMS (ESI) 
m/z calcd for C37H40N5O8S2 [M+H]+: 746.2313, found [M+H]+ 746.2311. 
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Compound 1.4. A round-bottom flask containing 5.18 (0.601 g, 0.821mmol), and 
a magnetic stirring bar was evacuated and then refilled with nitrogen. The evacuation and 
nitrogen-filling cycle was repeated for two more times. Dry CH2Cl2 (6 mL) and 2-
cyanoethyl-N,N,Nʹ,Nʹ-tetraisopropylphosphoramidite (0.272 g, 0.29 mL, 0.903 mmol) 
were then added via syringes. A 1H-tetrazole solution in CH3CN (0.45 M, 2.0 mL, 0.903 
mmol) was added via a syringe in one portion. After stirring at room temperature for 2 
hours, the reaction mixture was concentrated to dryness by blowing nitrogen over the 
surface. The residue was purified with flash column chromatography (1:1 hexanes/EtOAc) 
giving compound 1.4 as a white foam (0.600 g, 77%): Rf = 0.5 (EtOAc/MeOH = 29:1); 
1H NMR (400 MHz CDCl3) δ 1.12-1.15 (m, 12H), 1.97-2.03 (m, 2H), 2.32-2.95 (m, 8H), 
3.33-3.34 (d, J = 4 Hz, 2H), 3.51-3.63 (m, 4H), 3.73 (s, 6H), 3.93-3.98 (t, J = 10 Hz, 1H), 
4.24-4.47 (m, 1H), 4.49-4.51 (d, J = 8 Hz, 2H), 4.68-4.74 (m, 1H), 6.17-6.20 (t, J = 6 Hz, 
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1H), 6.73-6.76 (m, 4H), 7.13-7.38 (m, 9H), 7.74 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
20.2, 20.3, 24.5, 24.5, 24.6, 26.8, 39.4, 42.1, 43.2, 43.3, 55.2, 57.8, 58.0, 63.7, 65.6, 73.7, 
73.8, 84.6, 86.0, 86.3, 113.1, 117.3, 121.7, 126.9, 127.8, 128.0, 130.0, 135.7, 137.5, 144.5, 
146.2, 148.0, 153.0, 158.5; 31P NMR (162 MHz, CDCl3) δ 149.4. 
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Chapter 7  
Future Research Plan 
Modified ODNs that contain electrophilic and base-labile functionalities have 
important applications in many research areas including antisense drug development and 
chemical biology. In the previous chapters, we have described our development of a 
novel ODN synthesis technology. We used the Dmoc function to protect the amino 
groups of nucleoside bases and to link ODNs to solid support. With this protecting and 
linking strategy, deprotection and cleavage were able to be carried out under non-
nucleophilic conditions. This technology shall enable the synthesis of electrophilic ODN 
analogues. However, at the current state, in the deprotection step, we used the non-
nucleophilic base DBU to remove the 2-cyanoethyl phosphate protecting groups. As a 
result, we could not use the technology to synthesize base-labile ODNs. One future 
direction of this project will be to replace the 2-cyanoethyl phosphate protecting groups 
with Dim groups so that the technology is not only suitable for the synthesis of 
electrophilic but also base-labile ODNs. Furthermore, the deprotection technology of 
ODN synthesis under non-nucleophilic oxidative conditions can be optimized by using 
other Dmoc-alike protecting groups. For example, the protecting groups using 1,3-
dithianylethoxycarbonyl (Deoc) function, which can also be removed upon oxidative 
conditions, will be applied to protect the exo-amino groups of nucleoside bases. Due the 
more stable side product from the removal of Deoc functions, we are expecting less 
occurance of ODN conjugates from Michael addition. 
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 7.1 Dim Protecting Groups for Phosphoramidites 
Although we are satisfied with the non-nucleophilic conditions for the 
deprotection and cleavage of ODN synthesis, our technology is still limited. As we used 
DBU for removing cyanoethyl group, some base-labile ODN analogues are not 
compatible with our technology. In this case, we designed another type of protecting 
groups using 1,3-dithian-2-yl-methyl (Dim) moiety to protect P(III) of phosphoramidite. 
The resulted phosphoramidites are shown in Figure 7.1.  
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Figure 7.1. Dim-protected phosphoramidites 
Applying dT-Dmoc-CPG 1.1 and phosphoramidites (7.1-7.4) on ODN synthesis, 
ODN anchored CPG 7.5 will be obtained. Upon oxidation of the sulfide in Dim and 
Dmoc moieties, due to the drastically increased acidity of H-2, the Dim groups, Dmoc 
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groups and linker are expected to be readily cleaved under oxidizing conditions without 
any base present. As shown in Scheme 7.1, the deprotection and cleavage of 7.5 under 
neutral conditions will afford ODN 7.6. 
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Scheme 7.1. Proposed deprotection and cleavage utilizing Dim-protected 
phosphoramidites 
7.2 Deoc Protecting Groups for Nucleoside Bases 
In our described technology, aniline was used as a scavenger to deactivate the 
produced Michael acceptors from removal of Dmoc moieties. To simplify deprotection 
process, we designed a 1,3-dithianyl-ethoxycarbonyl (Deoc) function as protecting 
groups for nucleoside bases. The designed Deoc-protected phosphoramidite monomers 
are shown in Figure 7.2. Due to the additional methyl group, the adducts from removing 
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Deoc moieties will be more stable comparing to the adducts from Dmoc moieties. They 
will be less reactive toward nucleoside bases through Michael conjugative addition. 
Therefore, we might be able to avoid adding scavengers during the deprotection and 
cleavage process. 
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Figure 7.2. Deoc-protected phosphoramidite monomers 
The syntheses of Deoc-protected phosphoramidites have already been carried out. 
So far, we have successfully introduced Deoc function to nucleoside bases (Scheme 7.2). 
Phosphorylation of 7.10 will give 7.7. With several more steps ahead such as DMTr 
protection and phosphorylation, reactions of 7.12 and 7.13 will afford corresponding 
phosphoramidites 7.8 and 7.9. 
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Scheme 7.2. Introduction of Deoc moieties to nucleoside bases 
7.3 Conclusion 
The future research plan will extend our ODN synthesis technology from being 
only useful for the synthesis of electrophilic ODNs to being useful for the synthesis of 
base-labile ODNs as well. In addition, with the introduction of the Dim phosphate 
protecting groups, DBU treatment can be avoided, which can simplify the deprotection 
step. That is, deprotection can then be achieved in a single step instead of two steps. The 
introduction of Deoc protecting groups to replace the Dmoc groups in the technology will 
help to avoid using aniline as a scavenger. At the current stage of the technology, we used 
large amount of this scavenger, which takes efforts to remove it from product. With Deoc, 
the deprotection and cleavage procedure can be further simplified.  
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 Figure A.1. 1H NMR of compound 4.6  
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 Figure A.2. 13C NMR of compound 4.6 
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 Figure A.3. 1H NMR of compound 4.7  
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 Figure A.4. 13C NMR of compound 4.7 
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 Figure A.5. 1H NMR of compound 4.8  
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 Figure A.6. 13C NMR of compound 4.8 
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 Figure A.7. 1H NMR of compound 4.9 
  
133 
 
 Figure A.8. 13C NMR of compound 4.9 
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 Figure A.9. 1H NMR of compound 4.10 
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 Figure A.10. 13C NMR of compound 4.10 
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 Figure A.11. 1H NMR of compound 4.11 
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 Figure A.12. 13C NMR of compound 4.11 
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 Figure A.13. 1H NMR of compound 4.12 
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 Figure A.14. 13C NMR of compound 4.12 
  
140 
 
 Figure A.15. MALDI-TOF spectrum of compound 4.13 
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 Figure B.1. 1H NMR of compound 1.2 
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 Figure B.2. 13C NMR of compound 1.2 
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 Figure B.3. 31P NMR of compound 1.2 
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 Figure B.4. 1H NMR of compound 1.3 
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 Figure B.5. 13C NMR of compound 1.3 
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 Figure B.6. 31P NMR of compound 1.3 
  
148 
 
 Figure B.7. 1H NMR of compound 1.4 
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 Figure B.8. 13C NMR of compound 1.4 
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 Figure B.9. 31P NMR of compound 1.4 
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 Figure B.10. 1H NMR of compound 5.9 
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 Figure B.11. 13C NMR of compound 5.9 
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 Figure B.12. 1H NMR of compound 5.10 
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 Figure B.13. 13C NMR of compound 5.10 
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 Figure B.14. 1H NMR of compound 5.12 
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 Figure B.15. 13C NMR of compound 5.12 
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 Figure B.16. 1H NMR of compound 5.14 
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 Figure B.17. 13C NMR of compound 5.14 
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 Figure B.18. 1H NMR of compound 5.18 
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 Figure B.19. 13C NMR of compound 5.18 
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 Figure B.20. MALDI-TOF spectrum of compound 5.16 
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 Figure B.21. MALDI-TOF spectrum of compound 5.19 
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 Figure B.22. MALDI-TOF spectrum of compound 5.20 
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 Figure B.23. MALDI-TOF spectrum of compound 5.21 
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 Figure B.24. MALDI-TOF spectrum of compound 5.22  
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 Figure C.1. 1H NMR of compound 6.1 
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 Figure C.2. 13C NMR of compound 6.1 
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 Figure C.3. 1HNMR of compound 6.2 
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 Figure C.4. 13C NMR of compound 6.2 
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